Introduction {#s1}
============

Synapse development, maintenance and plasticity involve highly orchestrated trafficking events in both pre and postsynaptic cells. In contrast to postsynaptic receptors, whose trafficking and organization has been studied extensively in many different synapse types ([@bib16]), much less is known about the mechanisms that regulate the assembly and maintenance of the neurotransmitter release machinery in the presynaptic neuron. This machinery includes the active zone (AZ), an electron-dense complex of structural proteins that scaffold both calcium channels and synaptic vesicles (SV) for the coordination of calcium-regulated exocytosis ([@bib91]). The protein components of the AZ are synthesized in cell bodies and trafficked together in association with vesicles (known as piccolo-bassoon transport vesicles (PTVs) ([@bib2]; [@bib61]; [@bib82]). SV precursors are also synthesized in cell bodies, and carried by kinesin motors to synapses ([@bib34]; [@bib74]). Regulation of synapse development likely involves a global coordination of the synthesis and transport of both AZ and SV components. However the mechanisms that regulate these important steps in synapse development and maintenance are poorly understood.

A critical role in synapse development has been assigned to the kinesin-3 family of motor proteins ([@bib34]; [@bib48]; [@bib72]; [@bib76]; [@bib110]). Mutations in mammalian *Kif1a* and its *unc-104* orthologues in *C. elegans* and *Drosophila* (also known *as imac, Klp53D and bris in Drosophila*) cause severe defects in synapse development. In *Drosophila unc-104-null* mutants, synaptic boutons fail to form, SV and AZ components fail to traffic to nascent synapses, and concomitantly, SV and AZ associated proteins accumulate in the cell body ([@bib76]). It is broadly accepted that Unc-104 protein functions as a molecular motor to physically deliver presynaptic components to their destinations in the synaptic terminal ([@bib30]). However, while there is biochemical evidence that KIF1A can interact with and 'carry' SV precursors ([@bib74]), there is little evidence that KIF1A (or Unc-104) carries AZ components. The mechanistic role of Unc-104 in AZ transport and assembly remains unclear.

In this study we found that synaptic defects in embryonic *unc-104-null* mutants, including the failure to form synaptic boutons and AZs, arise not from direct loss of Unc-104 transport function, but via an indirect mechanism, which involves activation of the Wnd/DLK axonal damage signaling pathway. The Wnd/DLK mixed lineage kinase has recently received intense interest for its roles in regulating both regenerative and degenerative responses to axonal damage in vertebrate and invertebrate neurons ([@bib27]; [@bib36]; [@bib57]; [@bib92]). We found that the Wnd/DLK signaling pathway becomes activated when Unc-104's function is impaired, and then promotes synaptic dysfunction by restraining expression of multiple pre-synaptic AZ and SV protein components. This restraint concomitantly reduces protein buildup in cell bodies, which may play an adaptive role to stresses that disrupt intracellular transport, and contribute to pathologies that arise when transport is disrupted.

Results {#s2}
=======

Roles for the Unc-104 kinesin in AZ transport and synaptic bouton growth can be functionally separated from SV transport {#s2-1}
------------------------------------------------------------------------------------------------------------------------

Previous studies of NMJ development in *unc-104-null* mutant animals have revealed essential roles for this kinesin in synaptic maturation ([@bib34]; [@bib48]; [@bib76]; [@bib110]). At the *Drosophila* neuromuscular junction (NMJ), *unc-104-null* mutants are severely defective in the formation of presynaptic boutons, fail to localize SVs to NMJ terminals and show strong reductions in AZ localization ([@bib76] and [Figure 1](#fig1){ref-type="fig"}). We found that disrupting the axonal damage signaling kinase Wnd (*wnd^3^* single mutants) had no significant effect on bouton formation, AZ number, or presynaptic protein localization, but double mutants with *unc-104-null* alleles (*unc-104^P350^*, *unc-104^170^,* and *unc-104^52^*), gave a very informative phenotype: in *unc-104^null^;wnd^3/3^* double mutants the synaptic bouton formation ([Figure 1A and C](#fig1){ref-type="fig"}), AZ number ([Figure 1A and D](#fig1){ref-type="fig"}), and synaptic levels of the AZ protein Brp ([Figure 1A and E](#fig1){ref-type="fig"}) were restored to a wild type phenotype. In contrast, the synaptic levels of SV proteins (VGlut, SytI and CSP) remained negligible, as in the *unc-104^null^* single mutants ([Figure 1B and E](#fig1){ref-type="fig"}). These results are consistent with previous findings that Unc-104 functions as an essential molecular motor to transport SV precursors to synaptic terminals. However our findings indicate that transport of AZ precursors and bouton formation can occur independently of Unc-104. These defects are mediated by a second and separable mechanism, which depends upon the function of the Wnd kinase.

![AZ transport and Synaptic bouton formation but not SVP transport defects in *unc-104-null* mutants are rescued by mutations in *wnd*.\
Representative images of ISNb neuromuscular junction (NMJ) terminals at muscles 6, 7, 12 and 13 at embryonic stage 17 (20--21 hr AEL). We observed similar results with multiple independently generated *unc-104-null* alleles including *unc-104^P350^*, *unc-104^170^*and *unc-104^52^*. Representative images with *unc-104^P350^* are shown here. (**A**) Images of ISNb NMJ terminals immunostained for a neuronal membrane marker to show axons and terminal boutons (HRP, green in upper panel) and the AZ component Brp (magenta in upper panel, white in lower panel). Boutons failed to form and AZs failed to localize to NMJ in *unc-104^null^* mutants. Both defects were restored in *unc-104^null(P350)^;wnd^3^* mutants. (**B**) Images of ISNb NMJ terminals immunostained for presynaptic vesicle proteins (VGlut, upper panels; SytI, lower panel). The insets show HRP staining of the nerve terminals. Note VGlut and SytI failed to localize to NMJ in both *unc-104^null(P350)^* and *unc-104^null(P350)^; wnd^3^* mutants. (**C**) The bouton formation defect was quantified as the percentage of ISNb NMJ terminals that contained at least one presynaptic varicosity, identified by HRP staining (and scored while blind to genotype). This method over-estimates the actual number of boutons in unc-104*^null^* mutants, since any varicosity within any of the ISNb terminals (on muscles 6, 7, 12 or 13) was counted. (**D**) The number of AZs (identified as Brp punctae) formed at ISNb NMJ terminals (on muscles 6, 7, 12 and 13). (**E**) The total (sum) intensity of Brp, VGlut, SytI and CSP measured across the ISNb NMJ terminals. All data are represented as mean ±SEM; At least 9 animals and 20 ISNb NMJ terminals were examined per genotype; N.S., not significant; \*\*\*\*p\<0.0001, \*p\<0.05; Tukey test for multiple comparison; Scale bar, 10 μm.](elife-24271-fig1){#fig1}

The Wnd signaling pathway mediates presynaptic defects in *unc-104-hypomorph* mutants {#s2-2}
-------------------------------------------------------------------------------------

To further study the effect of Wnd upon AZ assembly we utilized several hypomorphic *loss-of-*function mutations of *unc-104*, whose ability to survive to the third instar larval stage has allowed for extensive characterization of synaptic defects associated with Unc-104 ([@bib6]; [@bib13]; [@bib48]; [@bib113]; [@bib112]). We used the EMS-generated alleles *bris/null* ([@bib48]) and *O3.1/null* ([@bib6]), and knockdown in motoneurons via independent RNAi lines. All of these mutants share similar characteristics: Post Synaptic Densities (PSDs) form (identified by the presence of a core receptor subunit GluRIII), however \~50% lack apposing presynaptic AZ components, as identified by Brp ([Figure 2A and C](#fig2){ref-type="fig"}), Liprin-α ([Figure 2B and D](#fig2){ref-type="fig"}) and the voltage gated calcium channel Cac-GFP ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). This defect is accompanied by a reduction in the levels of Brp within individual synapses and also across entire NMJ terminals ([Figure 2E](#fig2){ref-type="fig"}). Similarly to the *unc-104-null* mutants ([Figure 1](#fig1){ref-type="fig"}), mutations in *wnd* fully rescued these presynaptic AZ assembly defects ([Figure 2A--E](#fig2){ref-type="fig"}). RNAi knockdown of *unc-104* using either pan-motoneuron or single motoneuron driver lines led to AZ defects and concomitant knockdown of *wnd* in neurons led to rescue, ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), indicating a cell-autonomous role for both Unc-104 and Wnd in the synaptic defects.

![Wnd signaling pathway is required for the presynaptic defects in *unc-104-hypomorph* mutants.\
(**A--B**) Representative confocal images of third instar larval neuromuscular junctions (NMJ) at muscle 4. Postsynaptic densities (PSDs) identified by GluRIII staining (Green) that lacked apposing AZ components Brp (magenta in A), or Liprin-α (magenta in B) are highlighted by arrowheads. Note that when determining the absence of AZ components, the pixel saturation threshold was reduced to ensure detection ofweak signals (this resulted in saturation of certain pixels in wt controls. For more details, see Experimental Procedures.). (**A**) Alignment of postsynaptic GluRIII (green) with presynaptic AZ component Brp (magenta) in *Canton-S* (wt), *unc-104^bris/P350^*, *unc-104^bris/P350^;wnd^3^* and *wnd^3^. Unc-104^bris^* is a partial *loss of function* mutation ([@bib48]), *while unc-104^P350^* is a *null* allele ([@bib6]). *wnd^3^* is a presumptive null mutation in *wnd* ([@bib17]). (**B**) Alignment of postsynaptic GluRIII (green) with presynaptic AZ component Liprin-α (magenta). Liprin-α-GFP was driven by rab7 promoter and UAS-*unc-104* RNAi and UAS-*wnd* RNAi were driven by neuronal *elav*-Gal4. UAS-mCD8-RFP was used as a control for UAS dosage. (**C--D**) The percentage of PSDs which lack any trace of apposing presynaptic AZ protein, based on (**C**) Brp or (**D**) Liprin-α-GFP. (**E**) Signal intensity for Brp staining at individual synapses or summed across the entire NMJ terminal (at muscle 4), normalized to that in wt (*Canton S*) animals. (**F**) The total intensity of Vglut protein measured across the entire synaptic NMJ terminal at the muscle 4, normalized to that in wt (*Canton S*). All data are represented as mean ±SEM; At least 6 animals and 12 muscle 4 NMJ terminals were examined per genotype; \*\*\*\*p\<0.0001, \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05. Scale bar, 5 μm. For additional data, see [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"}--[2](#fig2s2){ref-type="fig"}.](elife-24271-fig2){#fig2}

In axonal regeneration and synaptic overgrowth, Wnd has been shown to act in a signaling pathway consisting of a cascade of MAP kinases and transcription factors ([@bib17]; [@bib71]; [@bib108]). We found that inhibition of the downstream MAP Kinase JNK (Bsk) and Fos transcription factor, via expression of dominant-negative (DN) isoforms in neurons, could also rescue the presynaptic defect shown in the *unc-104* single mutants ([Figure 2C](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). These results suggest that a signaling pathway consisting of Wnd, JNK and Fos mediates synaptic defects observed in *unc-104* mutants.

Suppression of *unc-104-hypomorph* defects reveals additional roles for the Wnd signaling pathway in restraining neurotransmission {#s2-3}
----------------------------------------------------------------------------------------------------------------------------------

In contrast with *unc-104-null* mutants, we observed that *wnd* mutations caused a striking increase in quantity of VGlut at *unc-104-hypomorphic* mutant NMJs ([Figure 2F](#fig2){ref-type="fig"}). The dramatic rescue of structural defects as well as SV protein localization at NMJs suggested that Wnd pathway mutations may also rescue synaptic transmission defects in *unc-104-hypomorph* mutants. *Unc-104-hypomorph* mutant NMJs have severely reduced mini frequency, and modestly reduced mEJP amplitude, EJP amplitude and quantal content ([@bib112]). We observed that mutations in *wnd*, *jnk* (*bsk*) or *fos* fully rescued the mEJP frequency defects ([Figure 3A and C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). mEJP amplitude, EJP amplitude and quantal content were also rescued by *wnd* mutations ([Figure 3](#fig3){ref-type="fig"}), while Bsk (JNK) and Fos inhibition rescued some aspects of these defects ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} and [Figure 3---source datas 1](#fig3sdata1){ref-type="supplementary-material"}--[3](#fig3sdata3){ref-type="supplementary-material"}). Through distribution analysis, we further confirmed the change in mEJP amplitude and validated the coverage of mEJP events for frequency analysis ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). The suppression of these phenotypes by mutations in *wnd* suggests that the Wnd pathway impairs multiple aspects of synaptic structure and transmission.

![The synaptic transmission defect in *unc-104* mutants is suppressed by *wnd* mutations.\
(**A--B**) Representative electrophysiological traces of (**A**) miniature Excitatory Junctional Potentials (mEJP) and (**B**) Evoked Excitatory Junctional Potentials (EJP) recorded from muscle 6 of third instar larvae. (**C**) Quantification of impaired mEJP frequency for *unc-104-hypomorph* mutants and their rescue by *wnd* mutations or expression of dominant negative (DN) *bsk* or *fos* (driven by *elav-*Gal4 and *BG380-*Gal4, respectively). Representative traces for *bsk^DN^* and *fos^DN^* are shown in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. (**D--F**) Quantification of (**D**) mEJP amplitude, (**E**) EJP amplitude and (**F**) quantal content (corrected for nonlinear summation). See also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} for additional quantification of *bsk^DN^* and *fos^DN^* data. *Unc-104^03.1^* and *unc-104^bris^* are hypomorphic alleles, while *unc-104^P350^* and *unc-104^d11204^* are null alleles. *wnd^3^* is a presumptive null mutation in *wnd* ([@bib17]). wt animals are *Canton S*. All data are represented as mean ±SEM; N.S., not significant; \*\*\*\*p\<0.0001, \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05. Tukey test for multiple comparison. For additional data, see [Figure 3---figure supplements 1](#fig3s1){ref-type="fig"}--[4](#fig3s4){ref-type="fig"}.\
10.7554/eLife.24271.012Figure 3---source data 1.Measurements of EJP and mEJP.The file contains data from 3 independent experiments and 6 source data sheets: EJP amplitude, corrected EJP amplitude and Quantal content, mEJP amplitude and frequency of CS, *unc-104*, *unc-104;wnd* and *wnd*. This is corresponding to [Figure 3](#fig3){ref-type="fig"}.\
10.7554/eLife.24271.013Figure 3---source data 2.Measurements of EJP and mEJP.The file contains EJP amplitude, corrected EJP amplitude and Quantal content, mEJP amplitude and frequency of CS, *unc-104^bris/d11204^*, *unc-104^bris/d11204^;bsk^DN^* and *bsk^DN^*. This is corresponding to [Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.\
10.7554/eLife.24271.014Figure 3---source data 3.Measurements of EJP and mEJP.The file contains EJP amplitude, corrected EJP amplitude and Quantal content, mEJP amplitude and frequency of CS, *unc-104^bris/O3.1^*, *unc-104^bris/O3.1^;fos^DN^* and *fos^DN^*. This is corresponding to [Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.](elife-24271-fig3){#fig3}

The total levels of Unc-104 protein remained low in the *unc-104^hypomorph^;wnd* double mutants ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Moreover, defects in larval motility and lethality of *unc-104-hypomorph* mutants largely remained in *unc-104^hypomorph^;wnd* double mutants, implying the persistence of major defects from the loss of Unc-104's function ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). Hence the extensive suppression of the synaptic defects at the larval NMJ is unlikely to be the result of increased stability of the residual Unc-104 protein. Instead, as indicated by the suppression of *unc-104-null* defects ([Figure 1](#fig1){ref-type="fig"}), the synaptic phenotypes reflect an activity of the Wnd pathway rather than a direct consequence of impaired Unc-104 driven transport.

Wnd signaling becomes activated when Unc-104's function is lost {#s2-4}
---------------------------------------------------------------

To test for Wnd signaling activation in *unc-104* mutants, we utilized a transcriptional reporter of JNK signaling, the *puckered* (*puc*)-lacZ enhancer trap ([@bib66]), which has been previously shown to report Wnd signaling activity in motoneurons ([@bib96]; [@bib108]). The basal expression of *puc*-lacZ is very low in wild type animals but was significantly increased in all *unc-104 LOF* mutant backgrounds (including *bris/null, O3.1/null,* and 2 independent RNAi lines) ([Figure 4A and B](#fig4){ref-type="fig"}). This increase was abolished when *wnd* was concomitantly knocked-down by RNAi ([Figure 4B](#fig4){ref-type="fig"}), hence reflects activation of a Wnd-mediated nuclear signaling cascade.

![The Wnd signaling pathway is activated in *unc-104* mutants.\
(**A**) Images of motoneuron cell bodies near the midline of larval ventral nerve cord, immunostained for motoneuron nuclear marker phospho-SMAD (magenta) and the Wnd/JNK nuclear reporter *puc*-LacZ (green). UAS-RNAi lines (including UAS-*moody* RNAi as a control) were driven by pan-neuronal *BG380*-Gal4. At least 3 dorsal abdominal clusters of motoneurons per VNC from 6 animals per genotype were examined. (**B**) Quantification of *puc*-lacZ expression in multiple *unc-104* mutant backgrounds. *Unc-104^03.1^* and *unc-104^bris^* are hypomorphic alleles, while *unc-104^170^* is a null allele. In addition we tested two independent *unc-104 RNAi* lines (vdrc 23465, I and TRiP BL43264, II). *Unc-104* RNAi II was accompanied with Dicer2 expression to facilitate the knock-down. Co-expression of *wnd-RNAi,* compared to UAS-*mCD8*-ChRFP reduced the effect of *unc-104* knockdown. The 'control' genotype has UAS-*mCD8*-ChRFP, (which serves as a control for dosage of UAS lines). Quantification methods are described in Experimental Procedures. (**C**) Presynaptic bouton morphology and branching at the NMJ, viewed via immunostaining for HRP (membrane marker) at muscle 4. The presynaptic arbor was over-branched in *unc-104 ^bris^* mutants compared to wt (*Canton S*) control animals, and this was rescued in *unc-104^bris^; wnd^1/3^* double mutants. (**D**) Quantification of presynaptic overgrowth was estimated by measuring the total NMJ length (from the most proximal to the most distal bouton of the presynaptic nerve terminal at muscle 4, labeled via anti-HRP staining). The data shown used *unc-104^bris^* and *wnd^1/3^* mutations, while UAS-*bsk^DN^* and UAS-*fos^DN^* were driven by *elav*-Gal4. wt control animals were *Canton S*. (**E**) Regenerative axonal sprouting of *m12*-Gal4, UAS-*mcd8*-GFP labeled axons 10 min, 9 hr or 18 hr after nerve crush from wt compared to *unc-104^O3.1(hypomorph)/P350(null()^* mutant animals. Asterisk (\*) indicates the injury site and arrow indicates the direction of the cell body. By 9 hr after nerve crush injury, axons in wild type animal initiate new growth via short filopodia-like branches from the proximal axonal stump. At 18 hr, a few branches are stabilized and grow either towards the distal axon or the cell body. In comparison, *unc-104* mutants showed a marked increase in new axonal branches at 9 hr, and at 18 hr these new axonal branches showed similar stabilization but extended nearly twice as far as wild type axons. (**F**) 9 hr after injury, the percentage of axons which contain more than 5 identifiable branches per axon. (**G**) The length of the longest branch per nerve at 18 hr after injury. *unc-104^O3.1/P350^* mutant and 2 independent *unc-104* RNAi lines and *control* RNAi (*moody-*RNAi) (driven by *m12*-Gal4) were examined. All data are represented as mean ±SEM; N.S., not significant; \*\*\*\*p\<0.0001, \*\*\*p\<0.001,\*p\<0.05, Tukey test for multiple comparison; Scale bar, 20 μm.](elife-24271-fig4){#fig4}

Additional evidence for Wnd signaling activation was revealed by the presynaptic nerve terminal morphology of *unc-104 hypomorphic* mutant NMJs, which show increased numbers of synaptic branches and boutons which are smaller in size (\[[Figure 4C and D](#fig4){ref-type="fig"}\], and Kern et al). These features of presynaptic nerve terminal overgrowth have previously been described for Wnd pathway activation ([@bib10]; [@bib17]; [@bib96]; [@bib105]). We confirmed that this overgrowth phenotype in *unc-104* mutants requires the function of Wnd, JNK and Fos in presynaptic motoneurons ([Figure 4C and D](#fig4){ref-type="fig"}).

Finally, we observed that *unc-104-hypomorph* mutants showed an enhanced ability to regrow axons after injury ([Figure 4E--G](#fig4){ref-type="fig"}). A potentially similar role in restraining axonal growth has recently been noted for *unc-104* during development in *C. elegans* ([@bib88]). Since previous studies have shown that activation of Wnd/DLK signaling enhances the ability of axons to initiate regenerative axonal growth after injury ([@bib35]; [@bib85]; [@bib108]; [@bib109]), the activation of Wnd signaling in *unc-104* mutants may explain this kinesin's paradoxical function in restraining rather than promoting axonal growth.

Previous studies have suggested links between JNK signaling and the regulation of axonal transport ([@bib25]; [@bib98]). It is therefore interesting that other mutations that disrupt axonal transport, including mutations which inhibit kinesin-1, dynein and dynactin, did not significantly affect the expression of *puc*-lacZ ([Figure 4B](#fig4){ref-type="fig"} and [@bib108]). Altogether, our results suggest a unique functional interdependence between Wnd pathway and the Unc-104 kinesin, and that the Wnd signaling pathway becomes activated when Unc-104's function is lost.

Wnd protein is mislocalized to the cell body in *unc-104* mutants {#s2-5}
-----------------------------------------------------------------

Previous studies have established that the protein levels of Wnd and its DLK homologues in mammals and *C. elegans* are strictly regulated, and positively correlate with the activity of Wnd signaling pathway ([@bib22]; [@bib37]; [@bib43]). A highly conserved ubiquitin ligase domain protein Hiw/Rpm-1/Phr1 restricts the levels of Wnd/DLK protein and inhibits Wnd/DLK signaling activation in wild type animals ([@bib3]; [@bib17]; [@bib71]; [@bib108]). Mutations in *hiw* lead to strongly elevated levels of Wnd protein whose localization can be detected in neurites and at synapses ([@bib17]). We therefore examined Wnd protein in *unc-104* mutants, for comparison to the previous characterized changes in *hiw* mutants.

In contrast to *hiw*, mutations in *unc-104* did not lead to a detectable increase in global levels of endogenous Wnd protein by Western Blot ([Figure 5A](#fig5){ref-type="fig"}), or in synaptic Wnd protein level ([Figure 5B](#fig5){ref-type="fig"}). In addition, *unc-104* mutants do not share the previously reported phenotype of *hiw* mutants of delayed axonal degeneration ([@bib107], and data not shown). These observations suggest that the mechanism of Wnd signaling activation in *unc-104* mutants is unlikely to occur via Hiw.

![Wnd signaling is activated via an unconventional mechanism in *unc-104* mutants.\
(**A**) Representative Western blot of larval whole brain extracts for endogenous Wnd and β-tubulin, and quantification of Wnd levels normalized to β-tubulin band intensity (n ≥ 3). Mutants examined include *unc-104^bris(hypomoprh)/P350(null)^*, *wnd^3^* and *hiw^ΔN^*. (**B**) Images of larval ventral nerve cords from MiMIC-*wnd*-GFP animals immunostained for GFP. Note the increased neuropil signal in *hiw* mutants, but not control or *unc-104* mutants. This also indicates that the MiMIC-*wnd*-GFP is, like endogenous Wnd ([@bib17]), subject to regulation by Hiw. (**C**) Images of motoneuron cell bodies in MiMIC-*wnd*-GFP animals immunostained with antibody against GFP. Compared to (**B**), these images are collected in a higher magnification and focal plane to view the motoneuron cell bodies. Two representative cell bodies are marked by green circles. At least 6 animals were examined per genotype. (**D**) Images of SNc motoneuron cell bodies via live-imaging in larvae expressing UAS-GFP-*wnd^kd^* (which is kinase dead to avoid pathway activation) driven by *m12-*Gal4. A representative cell body is marked by a green circle. At least 6 animals were examined per genotype. (**E--F**) Quantification of GFP signal intensity from (**C--D**) in cell bodies, normalized to wt (control) animals. Note that ectopically expressed GFP-*wnd* kinase dead protein has a higher basal expression level which allows for increased sensitivity in detecting changes to Wnd protein. (**G--H**) Representative images of presynaptic Brp and postsynaptic GluRIII from (**G**) *liprin-α^F3ex/R60^* and *liprin-α ^F3ex/R60^;wnd^1/3^* and (**H**) *rab3^rup^* and *rab3^rup^;wnd^3^*. Unapposed GluRIII-labeled PSDs are highlighted by arrowheads. Wt is *Canton S.*. (**I**) Percentage of unapposed GluRIII-labeled PSDs from (**G**) and (**H**). All data are represented as mean ±SEM; N.S., not significant, \*\*\*\*p\<0.0001; Tukey test for multiple comparison; Scale bar (**B--D**) 20 μm and (**G--H**) 5 μm. For additional data, see [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"}--[3](#fig5s3){ref-type="fig"}.](elife-24271-fig5){#fig5}

We then looked further at Wnd's localization using available reagents. By immunocytochemistry (IHC) with anti-Wnd antibodies, Wnd protein remained below the detection threshold in both wild type and *unc-104* mutant animals (data not shown). Therefore, to further evaluate potential effects upon Wnd protein we utilized two different wnd-GFP fusion proteins. First, a MiMIC-*wnd*-GFP line ([@bib97]), in which a GFP tag is inserted via an exon trap within the *wnd* genomic locus, creates another tool for detecting Wnd as expressed from its endogenous promoter. We verified that Wnd protein from this line was expressed and tagged ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). By IHC, this reagent revealed Wnd enrichment in neuronal cell bodies in *unc-104* mutants ([Figure 5C and E](#fig5){ref-type="fig"}). Second, an ectopically expressed UAS-GFP-*wnd^KD^* transgene (which was kinase dead to avoid pathway activation) has been established as a sensitive method to detect Wnd protein change ([@bib17]; [@bib37]; [@bib108]). This highly expressed transgene also revealed an increase in cell body localized Wnd in *unc-104* mutants ([Figure 5D and F](#fig5){ref-type="fig"}). This correlation of Wnd localization with signaling activation is interesting to note, since Wnd and its DLK homologue are known to physically associate with vesicles that are transported in axons ([@bib40]; [@bib108]), and this transport appears to be important for its ability to mediate axon-to-cell body retrograde signaling.

Does the cell body localization of Wnd reflect a role for Unc-104 in transporting Wnd-associated vesicles? From live imaging analysis of UAS- GFP-*wnd^KD^* vesicles we observed no impairment in transport kinetics or flux in *unc-104* mutants ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), and no co-localization for Wnd and Unc-104 (data not shown). Therefore we found no evidence for Wnd as a direct cargo of Unc-104.

Wnd inhibits presynaptic structure independently of the synaptic cargo Liprin-α and Rab3 {#s2-6}
----------------------------------------------------------------------------------------

We then considered the possibility that Unc-104 regulates Wnd signaling indirectly via the transport of another cargo. Previous work has suggested that other presumed cargo of Unc-104, including Liprin-α, Rab3 and Rab3-GEF, play important early roles in AZ assembly ([@bib31]; [@bib73]; [@bib84]; [@bib91]). We therefore asked whether defects in these synaptic 'cargos' of Unc-104 led to activation of Wnd signaling. We observed that *liprin-α* mutant NMJs contain a large portion of unapposed GluRIII-labeled PSDs ([Figure 5G](#fig5){ref-type="fig"}), resembling the defects in *unc-104* mutants. Similar defects were reported for *rab3* and *rab3-gef* mutants ([@bib5]; [@bib31]). However, in contrast to *unc-104*, the *liprin-α* and *rab3* synaptic defects were not suppressed by mutations in *wnd* ([Figure 5G--I](#fig5){ref-type="fig"}). Furthermore, the increased Brp intensity per AZ and reduced AZ number due to *liprin-α* and *rab3* mutations was not suppressed by *wnd* mutations ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). In fact, the Brp intensity per AZ was slightly enhanced in *liprin-α;wnd* double mutants. These data suggest that Liprin-α and Rab3 regulate presynaptic assembly via pathways that are either independent or downstream of Wnd, and that defects in synapse assembly and structure per se do not cause activation of Wnd signaling.

Activation of the Wnd signaling pathway in neurons is sufficient to impair presynaptic structure and synaptic transmission {#s2-7}
--------------------------------------------------------------------------------------------------------------------------

If Wnd signaling activation mediates synaptic defects in *unc-104* mutants, then activation of this pathway via other means should also induce *unc-104*-like synaptic phenotypes. Indeed, over-expression of *wnd* alone in motoneurons resulted in cell-autonomous presynaptic defects that are comparable to *unc-104* mutants. First, many individual synapses (identified by GluRIII puncta) lacked Brp ([Figure 6A and C](#fig6){ref-type="fig"}), and synapses that contained Brp had reduced Brp intensity, which resulted in a global 70% reduction in Brp intensity across the entire NMJ terminal ([Figure 6B](#fig6){ref-type="fig"}). Second, mEJP frequency, along with other aspects of synaptic transmission (amplitude of EJP and mEJP), was significantly impaired ([Figure 6D--I](#fig6){ref-type="fig"}). Third, synaptic localization of SV-associated proteins, measured by VGlut intensity within NMJ terminals, was also reduced ([Figure 6B](#fig6){ref-type="fig"} and [@bib17]). Taken together with the rescue of *unc-104* synaptic defects by *wnd* mutations ([Figures 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}), these data indicate that activation of Wnd signaling leads to strong perturbations in presynaptic structure and function.

![Activation of the Wnd signaling pathway in neurons is sufficient to impair presynaptic structure and synaptic transmission.\
(**A**) Representative images of SNc synapses at muscle 26, 27 and 29 with Brp and GluRIII staining. GluRIII-labeled PSDs that lack apposed AZs (highlighted by arrowheads) increased when Wnd was over-expressed. Similar defects were observed using a pan-motoneuron driver (*OK6-*Gal4), and in driver line specific to the SNc motoneuron (m12-Gal4), indicating the cell autonomy of Wnd's effect upon synapse assembly. (**B**) Quantification of Brp intensity at individual synapses or across entire NMJ terminals, and, similarly, total VGlut intensity across entire NMJ terminals (at muscle 4). Expression of UAS-*wnd* was driven with *ok6*-Gal4, and normalized to wt (*Canton S*). (**C**) The percentage of GluRIII-labeled PSDs which are unapposed by AZ component BRP. Quantification was carried out at SNc NMJ terminals in *hiw^ΔN^*, *unc-104^O3.1/P350^* and when UAS-*wnd* was over-expressed using either pan-motoneuron driver (*OK6*-Gal4) or a driver specific to SNc motoneurons (*m12*-Gal4). (**D--E**) Representative electrophysiological traces of (**D**) mEJP and (**E**) EJP on muscle 6 of third instar larvae in wt (*Canton S*) and *OE wnd* (expressed using the *ok6*-Gal4 driver). (**F--I**) Quantification of the (**F**) mEJP frequency, (**G**) mEJP amplitude, (**H**) EJP amplitude and (**I**) quantal content (corrected for nonlinear summation). All data are represented as mean ±SEM; N.S., not significant, \*\*\*\*p\<0.0001, \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05, Tukey test for multiple comparison; Scale bar, 2 μm. For additional data, see [Figure 6---figure supplements 1](#fig6s1){ref-type="fig"}--[2](#fig6s2){ref-type="fig"}.](elife-24271-fig6){#fig6}

As noted above, Wnd signaling also becomes activated when an upstream negative regulator, Hiw, is mutated ([@bib17]; [@bib71]). We found that *hiw* mutants displayed strikingly similar presynaptic defects to *unc-104* mutants or overexpression of Wnd ([Figure 6---figure supplements 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}). These included 60% of synapses lacking the AZ proteins Brp, Liprin-α and Cac ([Figure 6---figure supplement 1A,B and E](#fig6s1){ref-type="fig"}), a reduction of total Brp intensity at individual synapses and across the NMJ terminal ([Figure 6---figure supplement 1C--D](#fig6s1){ref-type="fig"}), a reduction in VGlut intensity at the NMJ terminal ([@bib17]), and reduced mEJP frequency ([@bib17]) and [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). All these presynaptic defects were rescued by *wnd* mutations. Meanwhile, a previously described Wnd-independent defect in quantal content remains in *hiw;wnd* double mutants ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, and [@bib17]). Taken together, these observations indicate that activation of the Wnd signaling pathway in multiple scenarios---in *unc-104* mutants, in *hiw* mutants, or when Wnd is ectopically over-expressed---all lead to a shared set of characteristic defects in presynaptic structure and synaptic transmission.

Wnd signaling restricts the expression level of presynaptic proteins in *unc-104* mutants {#s2-8}
-----------------------------------------------------------------------------------------

The above observations suggest that activation of the Wnd signaling pathway in *unc-104* mutants is the cause of many of the synaptic defects associated with Unc-104. However how Wnd signaling affects synapses, including both AZ and SV protein localization, is unknown. One of the hallmarks of the *unc-104* mutant phenotypes is the aggregation of protein components of both SVs and AZs in neuronal cell bodies ([@bib34]; [@bib76]). Strikingly, *wnd* mutations enhanced this phenotype: SV and AZ components were dramatically increased in cell bodies of *unc-104; wnd* double mutants ([Figure 7A,C,E](#fig7){ref-type="fig"}, and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). We observed a similar increase when either *bsk* or *fos* was inhibited in the *unc-104* mutant background ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}).

![Wnd restricts the expression level of presynaptic components Brp and VGlut in *unc-104* mutants.\
(**A--D**) Immunostaining for VGlut (green, (**A and B**) and Brp (magenta, (**C and D**) in motoneuron cell bodies (**A and C**) and NMJ terminals (**B and D**). In (**A**) motoneuron nuclei are indicated by Elav staining (blue). Note the increased intensity of VGlut and Brp in *unc-104^bris/P350^; wnd^3^* double mutants. (**E**) Quantification of VGlut and Brp intensity in cell bodies of motoneurons, corresponding to images in A and C. Note that total intensity measured at NMJ terminals is shown in [Figure 2E--F](#fig2){ref-type="fig"}. (**F**) Estimates generated for the total levels of VGlut and Brp proteins within motoneurons, accounting for the summed intensities measured in cell body, axonal, and synaptic compartments. Methods and assumptions used to calculate these estimates are described in Experimental Procedures. These proteins predominantly localize to the NMJ synaptic terminals (the proportion of the total protein localized to synapses is indicated with black shading). In *unc-104-hypomorph* mutants, a larger percentage is detected in cell bodies (medium gray shading), and the total summed intensity is reduced. In *unc-104; wnd* double mutants, the intensity increases in all of the compartments, cell body, axon (light gray shading) and synapse, compared to *unc-104* mutants alone. Wt animals are *Canton S*. (**G**) Images of motoneuron nuclei, immunostained for DsRed in *vglut* promoter-DsRed reporter lines. (**H**) Quantification of *vglut*-DsRed intensity in (**G**), normalized to *control*RNAi (*moody* RNAi). UAS-*RNAi* lines were driven by *OK6*-Gal4. For cell body analysis, at least 2 dorsal abdominal clusters of motoneurons per animal from at least 6 animals per genotype were examined. All data are represented as mean ±SEM; \*\*\*\*p\<0.0001, \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05, Tukey test for multiple comparison; Scale bar, 20 μm. For additional data, see [Figure 7---figure supplements 1](#fig7s1){ref-type="fig"}--[3](#fig7s3){ref-type="fig"}.](elife-24271-fig7){#fig7}

The exacerbated SV and AZ component accumulation in the neuronal cell bodies of *unc-104; wnd* double mutants seemed at first glance hard to reconcile with the suppression of synaptic defects in these animals. However, they may be explained by an action of the Wnd pathway within a feedback circuit to reduce the build-up of SV and AZ components in neuronal cell bodies. As a nuclear signaling cascade, we hypothesized that Wnd signaling may achieve this effect by down-regulating the expression levels of SV and AZ components. In this case, such reduction in global levels could account for the reduced levels at synaptic terminals in *unc-104* mutants. To test this hypothesis, we carried out quantitative immunohistochemistry to estimate the total cellular levels of Brp and VGlut in motoneurons based on respective intensities in cell body, axonal and synaptic compartments ([Figure 7F](#fig7){ref-type="fig"}). We found that compared with wildtype animals, the total levels of Brp and VGlut are reduced by 65% and 80% respectively in *unc-104* mutants ([Figure 7F](#fig7){ref-type="fig"}). The total levels of both proteins were restored in *unc-104; wnd* double mutants, with increases observed in all of the compartments (cell bodies, axons, and synapses). ([Figure 7F](#fig7){ref-type="fig"}). We suspect that the fact that motoneurons are only a fraction of neurons in the *Drosophila* nervous system prohibited our detection of global changes in these proteins by Western blot (data not shown). However we observed this trend in total levels of VGlut ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}). This may be facilitated by the fact that most of the glutamatergic neurons in larval VNCs are motoneurons.

These observations, combined with the observations that Wnd activation reduces the levels of Brp and VGlut at NMJs, suggest a model in which activated Wnd signaling leads to a down-regulation of the expression levels of multiple pre-synaptic proteins in *unc-104* mutants. This response may serve to counteract their buildup in neuronal cell bodies while causing the observed defects in synapse structure and function. In support of this, *unc-104* mutations led to decreased expression of a *vglut*-DsRed transcriptional reporter in motoneurons, in a Wnd-dependent manner ([Figure 7G and H](#fig7){ref-type="fig"}). This, together with the involvement of transcription factor Fos in restraining VGlut and Brp buildup in cell bodies ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}), implies that Wnd signaling may inhibit presynaptic protein expression at the transcriptional level.

Wnd delays the expression of SV proteins during early stages of synapse development {#s2-9}
-----------------------------------------------------------------------------------

We then asked whether Wnd signaling may also play a role during early synaptic development, when precise temporal coordination of presynaptic protein expression is critical for establishing synaptic contacts. Previous studies suggest that while Wnd/DLK signaling becomes activated in injured neurons, it is normally highly restrained in uninjured animals ([@bib17]; [@bib108]), and, in contrast to its essential role in responses to axonal injury, roles for Wnd in developmental axonal outgrowth or synapse formation have not been previously described ([@bib17]). We investigated this more carefully via analysis of *wnd-null* mutants during embryonic stages of axonal outgrowth and synapse formation (during embryonic stages 14 through 17), and observed that NMJ synapse development progressed normally ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}).

However, *wnd* mutants showed a premature onset of SV protein expression ([Figure 8](#fig8){ref-type="fig"}). In wild type embryos VGlut protein expression was undetectable until late embryonic stage 15, which coincides with the time at which motoneuron axons first reach their target muscles ([@bib44]). VGlut first appears in cell bodies ([Figure 8A--C](#fig8){ref-type="fig"}) and then becomes detectable at synapses at stage 16 and beyond ([Figure 8D](#fig8){ref-type="fig"}), consistent with continued expression and transport to synaptic terminals as the NMJ terminal expands. In *wnd* mutants VGlut expression levels resemble wild type at stage 16 and beyond, however its initial expression in cell bodies became apparent at an earlier time point, in early embryonic stage 15 ([Figure 8B--C](#fig8){ref-type="fig"}). SytI intensity was also increased in *wnd* mutants at early embryonic stage 16 ([Figure 8E--F](#fig8){ref-type="fig"}). These results suggest that endogenous Wnd signaling may function in pacing the onset of expression of SV proteins. This function may prevent unwanted buildup at inappropriate time points before synaptic contacts are established.

![Wnd delays the expression of SV proteins during early stages of synapse development.\
(**A**) Schematic cartoon of the embryonic nerve cord showing the neuropil (the location of neurites and developing synapses in the CNS) and motoneuron cell bodies in 2 segments at late embryonic stages (15 to 16). (**B**) Representative images of VGlut (white, bottom row) expression in motoneuron cell bodies of wt (*w118*) and *wnd-null* mutants (*wnd^3^*/*Df*) at embryonic stage early 15, late 15 and 16. Analogous segments are identified by neuropil HRP staining (top row). (**C--D**) Quantification of VGlut intensity in (**C**) motoneuron cell bodies and (**D**) NMJ presynaptic terminals for wt and *wnd-null* mutants at different embryonic stages and in third instar larvae. VGlut expression first appears in cell bodies at embryonic stage 15 (**C**), corresponding with the onset of NMJ synaptogenesis, but does not appear at NMJ terminals until stage 16 (**D**). As the NMJ matures and expands throughout development, VGlut intensity, which is predominantly localized to NMJ terminals, continues to increase (note the logarithmic scale). Quantification in both (**C**) and (**D**) is normalized to intensity for wt (*w118*) animals at stage 16. (**E**) Representative images of SytI immunostaining in CNS neuropil and NMJs. SytI intensity is elevated in *wnd^3^/Df* mutants at embryonic stage 16. (**F**) Quantification of SytI intensity from (**E**), normalized to intensity for wt (*w118*) animals. (**G**) Quantification of *puc*-lacZ expression in third instar larvae that ectopically express luciferase or presynaptic components (Brp, SytI, VGlut and VGlut^A470V^) via the Gal4/UAS system. Pan neuronal Gal4 (*BG380*) was used to drive expression of UAS-lines. All data were represented as mean ±SEM; \*\*\*\*p\<0.0001, \*\*p\<0.01, \*p\<0.05, Tukey test for multiple comparison; Scale bar, 20 μm. For additional data, see [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}.](elife-24271-fig8){#fig8}

Wnd signaling is sensitive to misregulated presynaptic proteins {#s2-10}
---------------------------------------------------------------

Across our cumulative observations, we noticed an interesting correlation between the activity of Wnd signaling and the appearance of presynaptic proteins localized in motoneuron cell bodies. During development, the role of Wnd in restraining VGlut was most significant immediately after the onset of VGlut expression in cell bodies and before its transport to synaptic terminals ([Figure 8B--D](#fig8){ref-type="fig"}). The same Wnd dependent pattern was observed for SytI ([Figure 8E--F](#fig8){ref-type="fig"}). Similarly, in *unc-104* mutants, the highly elevated activity of Wnd signaling to restrain the expression of presynaptic components coincided with their accumulation in neuronal cell bodies ([Figure 7](#fig7){ref-type="fig"}).

If mislocalized or misregulated presynaptic proteins play a causal role in the induction of Wnd signaling, then over-expression of these proteins should lead to an activation of Wnd signaling independently of their impact on synaptic function. To test this, we individually overexpressed three different components pan-neuronally: Brp, SytI and VGlut. Each caused a significant induction of the Wnd responsive *puc*-lacZ reporter ([Figure 8G](#fig8){ref-type="fig"}). In contrast, over-expression of other proteins (Luciferase ([Figure 8G](#fig8){ref-type="fig"}) and membrane localized GFP ([Figure 4B](#fig4){ref-type="fig"}), had no effect. Over-expression of VGlut can also lead to increased synaptic transmission ([@bib19]), however we observed that over-expression of a non-functional VGlut transgene, VGlut^A470V^, which has no effect upon synaptic physiology ([@bib19]), caused a similar induction of *puc*-lacZ expression ([Figure 8G](#fig8){ref-type="fig"}). These results, taken together with the cell autonomous nature of Wnd activation in *unc-104* mutants ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), suggest that Wnd signaling is sensitive to accumulations of presynaptic proteins in cell bodies.

Discussion {#s3}
==========

Synaptic defects in *unc-104* mutants are caused by activation of the Wnd/DLK signaling pathway {#s3-1}
-----------------------------------------------------------------------------------------------

The kinesin-3 family member Unc-104/KIF1A is known to be an important mediator of synaptic development and maintenance: mutations in *unc-104* and its homologues inhibit the localization of SV and AZ precursors to nascent synapses, causing profound synaptic defects ([@bib6]; [@bib34]; [@bib48]; [@bib58]; [@bib72]; [@bib75]; [@bib76]; [@bib110]; [@bib113]). While these synaptic defects have been considered logical outcomes of defective transport, we found that major aspects, including impaired AZ addition and development of synaptic boutons, are not mediated by a direct transport role for the Unc-104 protein. Rather, the *unc-104^null^;wnd* double mutants reveal separable functions for Unc-104: (1) Transport of SV precursors to synaptic terminals is likely a direct function, since the failure to deliver adequate VGlut, Syt1 and CSP persists in *unc-104^null^;wnd* double mutants, and the Unc-104 homologue KIF1A physically interacts with SV precursors ([@bib74]). (2) Regulation of bouton formation and localization of AZs is an indirect function, since this defect can be rescued in *unc-104^null^;wnd* double mutants (in the complete absence of Unc-104 function).

With the knowledge that the Wnd/DLK signaling pathway is activated in *unc-104* mutants, it is now worth considering whether it contributes to other phenotypes previously described for Unc-104 and its homologues in other species. These include impaired dendritic branching ([@bib48]), increased microtubule dynamics ([@bib14]), and failed neuronal remodeling ([@bib77]). It now becomes likely that these defects are mediated by Wnd/DLK, since Wnd/DLK signaling has previously been shown to influence microtubule growth ([@bib39]; [@bib56]), neuronal remodeling ([@bib52]; [@bib64]) and dendrite growth ([@bib100]). *Unc-104/Kif1a* mutants also show accelerated motor circuit dysfunction in aging animals ([@bib58]), impaired BDNF-stimulated synaptogenesis ([@bib50]) and neuronal death ([@bib110]). These phenotypes may also be facilitated by activation of DLK, which impairs synaptic development and function (this study and [@bib71]), and has also been shown to mediate neuronal death in some contexts ([@bib15]; [@bib78]; [@bib104]; [@bib103]). Human mutations in *KIF1A* have been associated with hereditary spastic paraplegia (SPG30) ([@bib23]), and hereditary sensory and autonomic neuropathy type IIC (HSN2C) ([@bib80]). The possibility that DLK activation mediates deleterious aspects of these disease pathologies becomes an interesting future question.

The Wnd/DLK pathway is sensitive to defects in Unc-104-mediated transport {#s3-2}
-------------------------------------------------------------------------

How does the Wnd pathway become activated in *unc-104* mutants? The mechanism(s) that lead to activation of Wnd and its DLK homologues are of general interest for their roles in axonal regeneration as well as degeneration and neuronal death. In addition to axonal injury ([@bib101]; [@bib104]; [@bib108]), disruption of microtubule and/or actin/cortical cytoskeleton can lead to activation of DLK ([@bib96], [@bib95]). Moreover, many studies have noted a role for DLK signaling in mediating structural changes in neurons downstream of manipulations that disrupt cytoskeleton ([@bib8]; [@bib64]; [@bib67]). Since the cytoskeleton is a closely functioning partner of all motor proteins, and is also implicitly affected by axonal injury, it is possible that these manipulations share a similar underlying mechanism with that of *unc-104* mutations. While disruption of cytoskeleton should impair transport by many motor proteins, mutations that impair kinesin-1 and dynein do not lead to activation of Wnd ([Figure 4](#fig4){ref-type="fig"} and [@bib108]). This specificity suggests that disruption of Unc-104 mediated transport, potentially via mislocalization of Unc-104's cargo, mediates Wnd/DLK's activation after cytoskeletal disruption and potentially after axonal injury.

This line of reasoning leads to further consideration of Unc-104's cargo. Our live imaging data do not support a simple model that Wnd is a cargo of Unc-104 ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). Known cargo of Unc-104 are important for the assembly and function of synapses ([@bib30]), so does Wnd activation occur in response to an impairment in synaptic assembly or function? We think this is unlikely, since mutations in *rab3-gef*, *liprin-α* and *vglut*, which impair presynaptic assembly and function, do not cause activation of Wnd (data not shown).

Instead, we note an intriguing correlation between the localization and abundance of presynaptic proteins with Wnd's activation: Wnd signaling becomes activated in *unc-104* mutants, which accumulate presynaptic proteins in the neuronal cell body. We noticed a similar role for endogenous Wnd in wild type neurons during the onset of embryonic NMJ development ([Figure 8](#fig8){ref-type="fig"}). These stages correspond to the onset of synaptic protein expression, before substantial transport to synaptic terminals, hence represent a time in which levels are high in the cell body. Consistent with the idea that Wnd signaling is sensitive to mislocalized presynaptic proteins, ectopic overexpression of several different presynaptic proteins caused an elevation in Wnd signaling in uninjured neurons ([Figure 8G](#fig8){ref-type="fig"}). These observations suggest a model that accumulations of presynaptic proteins, as a feature of aberrant cargo transport, are 'sensed' by Wnd signaling ([Figure 9](#fig9){ref-type="fig"}).

![Model: Wnd/DLK signaling promotes synaptic defects by restraining total levels of presynaptic proteins when Unc-104's function is reduced.\
The formation and maintenance of synapses require the synthesis of presynaptic components (including AZ components (magenta dots) and SV components (green dots), which ultimately assemble into mature AZs (magenta 'T' bars) and SVs (green circles) at synapses. SV components are transported in the form of SV precursors (SVPs), while AZ components are thought to be transported via association with dense core vesicles (DCVs) ([@bib82]). While much remains to be learned about the mechanism by which individual synaptic components are transported, we can infer from this study that the Unc-104 kinesin (black) plays an essential role in the transport of SV components but not AZ components (which may be carried by an additional kinesin, indicated in gray). When Unc-104's function is impaired/reduced, presynaptic components accumulate in cell bodies. However Wnd signaling activation reduces the accumulations by reducing total expression levels of presynaptic components. This reduction eventually manifests as a reduction in synapse number and mismatched pre- and postsynaptic structures.](elife-24271-fig9){#fig9}

Wnd/DLK signaling restrains the expression of presynaptic proteins: mechanism and relevance {#s3-3}
-------------------------------------------------------------------------------------------

While previous studies in *C. elegans* ([@bib71]; [@bib109]) have suggested that DLK activation may impair synaptic development (altering the size and spacing of active zones), the regulation of total levels of presynaptic proteins and the relationship with Unc-104 provides a new view into Wnd/DLK's function and mechanism. In addition to VGlut, SytI, CSP-1, Brp, Liprin-α and Cac, we suspect that Wnd signaling restrains the expression of a cohort of presynaptic proteins. Regulation of multiple targets required for synapse development and maintenance can explain the severe defects in *unc-104-hypomorph* mutants, and the dramatic suppression by disruption of the Wnd pathway ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). In support of this idea, presynaptic defects in *unc-104-hypomorph* mutants can be partially rescued by overexpressing Brp ([@bib48]) or Rab3 ([@bib113]).

It is interesting to consider that the targets of Wnd regulation are also abundant presynaptic proteins, and are thought to be major cargo for axonal transport ([Figure 9](#fig9){ref-type="fig"}). Down-regulation of these proteins in response to defects in their transport or after axonal damage may comprise a stress response mechanism to prevent unwanted buildup or wasted cellular resources. This role may allow neurons adapt to stresses that impair axonal transport by counteracting cargo buildup. But the resulting reduction in synaptic protein levels can also be maladaptive, leading over time to synapse failure and/or loss. This feature may contribute to synaptic pathologies associated with defects in axonal transport.

How does Wnd signaling regulate presynaptic proteins? The regulation of the *vglut*-promoter-DsRed reporter and requirement for the Fos transcription factor suggests the involvement of transcriptional regulation ([Figure 7G--H](#fig7){ref-type="fig"}), and we also noticed mildly increased levels of Brp, VGlut and Cac transcripts in *unc-104;wnd* double mutants (data not shown). However we are limited in our ability to detect total changes in mRNA and protein levels from whole nerve cord preparations by the fact that the Wnd signaling pathway may not be acting in all cell types. It is also possible that additional post-transcriptional mechanisms, such as regulation of protein stability or translation, or bulk turnover via autophagy, factor into the regulation of presynaptic proteins by Wnd. A recent study has suggested that DLK may activate the integrated stress response pathway in mammalian neurons ([@bib53]). On the other hand, previous studies have separately linked Unc-104, Wnd signaling and AP-1 (Fos) to autophagy ([@bib33]; [@bib83]; [@bib88]). It will be interesting to determine whether translation and/or autophagy contribute to the regulation of presynaptic proteins by Wnd signaling.

Many previous studies have reported links between JNK signaling and kinesin-driven transport ([@bib98]), with some observations suggesting that JNK signaling may directly regulate the function of kinesin-1, modulating its cargo binding, affinity for microtubules and its processivity ([@bib24]; [@bib42]; [@bib69]; [@bib87]; [@bib90]). Our finding of a separate role for JNK signaling in regulating the abundance of transported cargo adds a new layer of complexity to interpreting phenotypes of axonal transport defects. A commonly described defect is the presence of accumulations of cargo within axons, referred to as 'traffic jams'. These defects have been noted for many different mutations, including kinesin-1 and dynein subunits ([@bib29]; [@bib51]; [@bib65]), and also in mutants for *wnd* and other members of JNK signaling pathways ([@bib9]; [@bib41], [@bib42]). Does a failure to regulate excess protein cargo contribute to the presence of the jams? Intriguingly, *unc-104* mutations do not cause this type of 'traffic jams' in axons, but instead leads to accumulations of synaptic proteins in cell bodies, which correlates with the activation of Wnd signaling.

Finally, it is interesting to compare Wnd's role in tuning levels of presynaptic proteins with previously identified roles for DLK in promoting cell death ([@bib15]; [@bib43]; [@bib78]; [@bib101]; [@bib104]). While *Kif1a* mutant mice show early signs of neuronal death and degeneration, which may potentially be mediated by activation of DLK, *unc-104* mutants in *C. elegans* and *Drosophila* lack hallmarks of cell death and synaptic degeneration ([@bib34]; [@bib48]; [@bib76]). In analogy with other stress response pathways, regulation of presynaptic proteins may comprise a first order response that may facilitate adaptation to stress, while cell death could be the consequence when compensatory mechanisms fail. Inhibition of synaptic proteins is, alone, a pathology that becomes relevant for long term maintenance of synapses and their function over time, since synthesis and transport of new synaptic proteins likely needs to occur throughout the long lifespan of a neuron. Interestingly, previous studies have linked activation of JNK signaling to synapse loss in aged animals ([@bib60]; [@bib81]; [@bib99]). Exciting future work lies ahead to further understand DLK's activation and its consequences in different models of neuronal injury, disease, and aging.

Note added at proof {#s3-4}
-------------------

Since acceptance of this work, a new publication has shown that DLK signaling contributes to pathology in multiple mouse models of neurodegenerative diseases ([@bib54]). This study provides further suggestive evidence that DLK signaling activation can contribute to synapse loss in disease conditions.

Materials and methods {#s4}
=====================

*Drosophila* stocks {#s4-1}
-------------------

The following strains were used in this study: *Canton-S*, *hiw^ΔN^* ([@bib106]), *wnd^1^*, *wnd^3^*, *wnd^dfED228^*([@bib17]), UAS-*wnd*^kinase\ dead^-GFP([@bib108]), MiMIC-*wnd*-GFP ([@bib97]), *unc-104^O3.1^*, *unc-104^P350^* ([@bib6]), *unc-104^bris^* ([@bib68]), *unc-104^d11204^* ([@bib93]), *unc-104^52^* ([@bib76]); UAS-*cacophony*-GFP([@bib47]), *OK6*-Gal4 ([@bib1]), *OK319*-Gal4, *OK371*-Gal4([@bib63]), *m12*-Gal4([@bib79]), *BG380*-Gal4([@bib12]),*elav*-Gal4^C155^([@bib59]), UAS-*fos^DN^* ([@bib20]), UAS-*bsk^DN^* ([@bib102]),*khc^8^, khc^27^*([@bib11]), *khc^k13314^*([@bib86]), *Liprin-α^F3ex15^*, *Liprin-α^R60^*([@bib46]), UAS-VGlut-GFP, UAS-VGlut^A470V^-GFP ([@bib32]), UAS-Brp-GFP (Bloomington (BL) 36291 and 36292), UAS-SytI-GFP (BL6925 and 6926), Rab7-*liprin-α*-GFP([@bib113]), *Rab3^rup^*([@bib31]), UAS-YFP-*Rab3*, UAS-YFP-*Rab3^Q80L^*, UAS-YFP-*Rab3^T35N^*([@bib111]), uas-mcd8-ChRFP (Schnorrer, 2009.5.11), *puc*-lacZ^E69^([@bib66]), *vglut* promoter-DsRed (gifts from Daniels and Diantonio), RNAi lines: *moody* RNAi (control), *Octβ2R* RNAi (vdrc 104524, control), *unc-104* RNAi (vdrc 23465, I and TRiP BL43264, II), *wnd* RNAi (vdrc 103410 and vdrc 26910), *Rab3* RNAi (TRiP BL31691 and BL34655), UAS-*Dcr2* was a gift from Stephan Thor (Linköping Université, Linköping Sweden). Flies were raised at 25°C or 29°C (as indicated for certain RNAi knock-down) on standard Semidefined yeast-glucose media ([@bib4]).

To generate *vglut*-DsRed reporter flies, genomic sequence spanning 5.3 upstream of the ATG start codon for *vglut* (CG9887) was cloned into a plasmid derived from pCaSpeR-AUG-bGal ([@bib94]), in which lacZ was replaced with DsRed.T4-NLS ([@bib7]) coding sequence, such that the expressed DsRed would concentrate in the nucleus.

Immunocytochemistry {#s4-2}
-------------------

Third-instar larvae were dissected in ice-cold PBS, then fixed in 4% formaldehyde (FA) in PBS/HL3 solution for 3 min for Cac-GFP, 10 min for Brp and GluRIII/GluRIIC staining or 20 min for other antibody staining, followed by blocking in PBS with 0.1% Triton (PBT) containing 5% Normal Goat Serum (NGS) block for 30 min. Control and experimental animals were always dissected, fixed and stained in the same condition and imaged in parallel using identical confocal settings.

Embryos were dissected, fixed and stained as described in ([@bib21]; [@bib55]). In brief, embryos were collected for 30--60 min on Molasses plates and kept in 18°C (for stage 14 to 16) or 25°C (for stage 17) overnight. Early-stage embryos (14-16) were dechorionated, sorted (based on GFP), staged (based on gut morphology \[[@bib38]\]) and dissected (tungsten needles) on negatively charged slides. Stage 17 embryos (20--21 hr AEL) were dissected with Vet glue (Vetbond) in PBS (PH = 7.3) on Sylgard-coated coverslips. Bouin's fixation for 5 min was used for all antibodies staining but Synapsin staining (4% PFA for 25 min). The examined *unc-104-null* alleles include *P350/P350* and *52/52*.

Primary antibody and secondary antibody incubations were conducted in PBT containing 5% NGS at 4°C overnight and at room temperature for 2 hr, respectively, with three 10 min washes in PBT after each antibody incubation. The following primary antibodies and dilutions were used: ms anti-Brp (DSHB Cat\# nc82 Lot\# RRID:[AB_2314866](https://scicrunch.org/resolver/AB_2314866)), 1:200; ms anti-Synapsin (DSHB Cat\# 3C11 (anti SYNORF1) Lot\# RRID:[AB_528479](https://scicrunch.org/resolver/AB_528479)), 1:50; ms anti-CSP-1 (DSHB Cat\# DCSP-1 (ab49) Lot\# RRID:[AB_2307340](https://scicrunch.org/resolver/AB_2307340)), 1:100; ms anti-DLG(DSHB Cat\# 4F3 anti-discs large Lot\# RRID:[AB_528203](https://scicrunch.org/resolver/AB_528203)), 1:1000; Rb anti-GluRIII (gift from Diantonio lab), 1:2500; Rb anti-SytI (gifts from Noreen Reist, [@bib62]), 1:400; Rb anti-Unc-104(Pack-Chung E; Nat Neurosci. 2007 Cat\# unc-104 Lot\# RRID:[AB_2569094](https://scicrunch.org/resolver/AB_2569094)), 1:500; ms anti-lac-Z (DSHB Cat\# 40-1a Lot\# RRID:[AB_528100](https://scicrunch.org/resolver/AB_528100)), 1:100; Rb anti-Phospho-Smad1/5 (Cell signaling),1:100; Rb anti-DsRed (Clontech Laboratories, Inc. Cat\# 632496 Lot\# RRID:[AB_10013483](https://scicrunch.org/resolver/AB_10013483)Clontech), 1:1000; Rat anti-elav (DSHB Cat\# Rat-Elav-7E8A10 anti-elav Lot\# RRID:[AB_528218](https://scicrunch.org/resolver/AB_528218)), 1:50; A488 rabbit anti-GFP (Molecular Probes Cat\# A-21311 also A21311 Lot\# RRID:[AB_221477](https://scicrunch.org/resolver/AB_221477)), 1:1000 and Alexa488/cy3/Alexa647 conjugated Goat anti-HRP (Jackson ImmunoResearch), 1:300. Rabbit anti-VGlut (gift from Diantonio lab), 1:10000, staining was carried as described in [@bib18]. For secondary antibodies we used Cy3- or A488-conjugated goat anti-rabbit or anti-mouse 1:1000 (Invitrogen).

Imaging and analysis {#s4-3}
--------------------

Confocal images were collected as described in ([@bib26]; [@bib108]). Similar settings were used to collect all compared genotypes and conditions.

The identification and quantification of the % unapposed PSD was based on manual counts of the total number of individual GluRIII-labeled puncta (on either muscle 4 or 26/27/29, where indicated), scored for the presence or absence of an apposing AZ component (Brp or Liprin-α-GFP). To affirm that AZ components were indeed completely absent, confocal settings and brightness levels were optimized for the weakest signals in *unc-104* mutants. Since the same settings were used for all genotypes some pixels for AZ components were necessarily over-exposed in the wt controls. For measurements of intensity levels, using Volocity software, only raw images acquired together using the same confocal settings were compared. To measure VGlut and Brp levels in axons and NMJs, we used staining for HRP (which labels neuronal membrane) to define the region of interest. For cell bodies, we selected the signal above a specified threshold, (To specify the threshold, we checked the background signal and examined the fluorescence signal distribution from multiple images. The threshold was chosen to be as at least 3 fold higher than the background and 1 SD higher than the center of the distribution. The same threshold was applied to all compared images). To estimate the total VGlut or Brp level within a single motoneuron ([Figure 6](#fig6){ref-type="fig"}), we summed measurements of: (a) total intensity for individual cell bodies (located in the dorsal midline of the ventral nerve cord), (b) total intensity for individual NMJ nerve terminals at muscle 4, and (c) estimated total intensity within a motoneuron axon, calculated from mean intensity in axonal segments, based on the assumption of 32 motoneuron axons per nerve and an average axon length of 1 mm.

When imaging nerve cord, we used 0.8 μm step size for the z-stack and focused on the posterior and central nerve cord, corresponding to A4-A8. When imaging axons or the NMJ, we used 0.4 μm step size for z-stacks. Axonal segments were imaged 900 μm away from the nerve cord. NMJ images were collected at segment A3 for muscle 4 or (when using the m12Gal4 driver) for muscle 26, 27 and 29, which are innervated by the SNc neuron. *puc*-lacZ level was measured within the nucleus region for motoneurons, selected by P-smad staining in the dorsal regions of A4-A8 in the ventral nerve cord.

For live imaging analysis of GFP-wnd-KD transport, third instar larvae were dissected in the center of a circle reinforcement label (Avery) in HL3 solution ([@bib89]) with 0.45 mM calcium. Larvae were pinned at the head, tail and 2 lower corners, the pins were then pushed into sylgard so that the coverslip could lie directly on top of the reinforcement label (and the larva), and excess HL3 solution was removed before imaging on an inverted microscope. Images were collected at 0.3 Hz for 5 min at 40x magnification in segmental nerves at a location 900 μm distal to the nerve cord. The images were then processed in imageJ with a kymograph plugin (Jens Rietdorf and Arne Seitz) and further analyzed in MATLAB with a program written to determine vesicle segmental speed and duration (described in [@bib28]).

Western blot {#s4-4}
------------

25--30 3^rd^ brains were collected in PBS and homogenized for each sample. The following antibodies and dilutions were used: rb anti-Wnd 4--3 ([@bib17]) 1:700; rb anti-VGlut ([@bib18], 1:10000; ms anti-Brp (NC82), 1:100; ms anti-β-tubulin (1E7, DSHB), 1:1000; and rb anti-unc-104 (Gift from Tom Schwarz lab), 1:500. The blots were probed with HRP conjugated secondary antibodies: Gt at-ms and Gt at-rb at the dilution of (1:5000) and imaged with either film or an Odyssey CLx imager (LI-COR).

Axonal regeneration {#s4-5}
-------------------

The nerve crush assay was carried out as described ([@bib108]), and animals were fixed either 9 or 18 hr after the injury. Axonal regeneration (sprouting) was quantified by measuring the number of injured axons that contained more than 5 branches at 9 hr, and the length of the longest branch at 18 hr.

Electrophysiology {#s4-6}
-----------------

Third instar larvae were dissected within 3 min in HL3 solution containing 0.65 mM Calcium at 22°C. Muscle 6 at segment A3 was located by the use of an OLYMPUS BX51WI scope with a 10x water objective and then recorded intracellularly with an electrode made of thick wall glass (1.2 mm x 0.69 mm) pulled by SUTTER PULLER P-97. Amplifier GeneClamp 500B and digitizer Digidata 1440A were used. The recording was only used if the resting potential was negative to −60 mV and muscle resistance was \>5 mΩ. A GRASS S48 STIMULATOR was used to obtain a large range of stimulation voltage range (1--70V). We noticed that *hiw* mutants and *unc-104* mutants required a higher stimulus to recruit the 2^nd^ axon that intervenes Muscle 6 (10--40V were required in *hiw* and *unc-104* mutants, as opposed to 2--8V in wild type). To ensure that we could always recruit both axons, for each muscle we tested a range of stimulation voltage (1--70V) to find the threshold which triggered the largest response within the testing range. A stimulus slightly larger than this threshold was then used at a frequency of 0.2 Hz and duration of 1 ms for EJP measurements. Axon Laboratory software was used for acquisition and the Mini Analysis program (Synaptosoft Inc) was used for analysis of mEJP frequency and amplitude. Parameters for Mini Analysis were set as: 0.2 (threshold), 1 (area threshold), 30,000 (period to search a local maximum), 40,000 (period to search a decay time), 40,000 (time before a peak for baseline), 20,000 (period to average a baseline), 0.6 (fraction of peak to find a decay time) and detect complex peak.

Quantal content and EJP amplitudes were corrected for non-linear summation using the revised Martin correction factor as described in ([@bib49]; [@bib70]). In brief, to accurately estimate the potential change if units sum linearly, the following equation was applied when EJP amplitude was larger than 15% of E^resting\ potential^: corrected EJP = EJP/(1 f(EJP/E^driving\ force^)), where E^driving\ force^=E^resting\ potential^-E^reversal\ potential^ and f = the membrane capacitance factor (Δt/τ). At the Drosophila NMJ, E^reversal\ potential^ is estimated around 0 mV, E^resting\ potential^ from our recordings is around −70 mV and f = 0.55 ([@bib49]; [@bib70]).

Data analysis {#s4-7}
-------------

The minimum sample size for animal lethality and motility was determined by power analysis using: sample size = 2\*SD^2^(Z~α/2~+Z~β~)^2^/d^2^, where SD = standard deviation, d = effect size and Z~α/2~ or Z~β~ are constants when α = 0.5 and β = 80% ([@bib45]). For other assays (including synapse morphology, electrophysiology, *pu*c-lacZ expression and axonal sprouting), the sample size and biological replicate number was determined for comparison with previous studies ([@bib108]; [@bib107]; [@bib17]; [@bib48]; [@bib28]). For axonal regeneration (sprouting), a total of 30 axons were measured from 8 individual animals. For comparison of intensities via confocal imaging and for structural analysis of synapse number and bouton number, at least 12 clusters of motoneurons within dorsal abdominal segments 2--5 (which contain 10 cell bodies per cluster), taken from at least 6 animals (2--3 clusters per animal) or 12 NMJs from at least 6 animals (2 NMJs per animal) were examined per genotype for each criteria quantified. For analysis of axonal transport, kymographs were generated and analyzed from a total of 60 axons from 10 individual animals. For electrophysiology, for each genotype we analyzed 35 individual EJP traces and a 45s-long mEJP trace per muscle for at least 11 muscles (derived from at least 6 independent animals -- 2 muscles per animal).

Data was analyzed by either Student's t-test (two groups) or one-way ANOVA followed by Tukey test (multiple groups). Normality of datasets for parametric/ANOVA was confirmed using the D'Agostino-Pearson-omnibus K2 test. p values smaller than 0.05 were considered statistically significant. All p values are indicated as \*p\<0.05, \*\*p\<0.01, and \*\*\*p\<0.001 and \*\*\*\*p\<0.0001. Data are presented as mean ±SEM.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"The Wallenda/DLK kinase restrains the expression of pre-synaptic proteins according to their transport\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The reviewers have opted to remain anonymous.

Li et al. present work investigating Wnd/DLK MAP kinase pathway regulation of expression levels of synaptic genes following disrupted axonal trafficking upon knockdown of Unc-104/Kif1a, a Kinesin 3 motor. Based on the exciting finding that loss of wnd suppresses the reduced presynaptic active zone (AZ) protein accumulation and associated functional deficits of unc-104 hypomorphic mutants, the authors propose a model in which the Wnd pathway \'senses\' levels of presynaptic proteins in the cell body and acts as a brake on expression when levels exceed the ability of the cell to transport these proteins to synapses. The experiments are generally carefully done and individual experiments serve the purpose of supporting the genetic interaction. However, as a whole, the paper worryingly feels like a catalog of correlative connections, missing conceptual depth. A consistent term used throughout the paper is \"modest effect\" or \"modest role\", suggesting ambiguity of the observations and the conclusions. Some of the issues could be addressed by re-writing, others need additional data. Thus, while this is an interesting model, it is not fully supported by the data presented as detailed below.

While some of our concerns can be addressed by better analysis and writing, others require significant experiments. We had prolonged discussions around whether these concerns can be addressed in two months and if done would we be persuaded. We feel that some suggested experiments which are critical to the thrust of the paper can be done in two months. Yet, when we asked if these concerns were addressed whether the model proposed and data presented would be acceptable despite \'mechanistic\' gaps, we were not persuaded. In this situation, another round of review would not be correct.

*Reviewer \#1:*

Li et al. present work investigating Wnd/DLK MAP kinase pathway regulation of expression levels of synaptic genes following disrupted axonal trafficking upon knockdown of Unc-104/Kif1a, a Kinesin 3 motor, and during development. Based on the exciting finding that loss of wnd suppresses the reduced presynaptic active zone (AZ) protein accumulation and associated functional deficits of unc-104 hypomorphic mutants, the authors propose a model in which the Wnd pathway \'senses\' levels of presynaptic proteins in the cell body and acts as a brake on expression when levels exceed the ability of the cell to transport these proteins to synapses. While this is an interesting model, it is not fully supported by the data presented as detailed below.

1\) Support for their model:

A\) The authors propose that unc-104 function can be divided into a transport role for SVs that is independent of Wnd and a Wnd/DLK pathway-dependent role in regulating AZ proteins. The differentiation between Brp and SV proteins is based on the finding that reduced synaptic levels of Brp in unc-104 nulls are suppressed by wnd but SV protein levels are not, in contrast to their findings in unc-104 hypomorphs. Simpler models should be considered. For example, the observation that wnd suppresses the loss of SV proteins at synapses in hypomorphs with residual Unc-104 activity but not nulls is more easily explained by the model that SV transport, but not Brp transport, is fully dependent on Unc-104, consistent with prior observations in *Drosophila* (Pack-Chung et al., 2007)..

B\) The strongest evidence for activation of Wnd in Unc-104 mutants comes from the puc-LacZ experiments in unc-104 RNAi lines ([Figure 3B](#fig3){ref-type="fig"}). Given the importance of this finding, it this experiment should be conducted in unc-104 null and hypomorphic mutants. It\'s not clear how the proposed model leads to the specificity for unc-104 reported here. Have the authors investigated if cell body levels of presynaptic proteins are increased in these other mutants?

In [Figure 8](#fig8){ref-type="fig"}, the authors show that GFP-tagged Wnd MiMIC lines show increased Wnd in unc-104 mutants when well-characterized antibodies to Wnd (Collins et al., 2006) fail to show an increase. If they are going to include this data, the authors should provide an explanation for why the MiMIC data might provide a better indication of the underlying biology.

C\) The evidence that Wnd regulates the levels of presynaptic protein levels and in particular that it acts at the level of transcription is somewhat inconsistent. Upon Wnd overexpression, the authors observed decreased protein levels at active zones as predicted. However, in wnd null embryos they see increased levels in some proteins at some stages, but decreases in other proteins (e.g., Brp). This and the absence of a consistent effect on the timing or expression, weakens their conclusion that wnd controls the levels and timing of expression of AZ and SV components.

In [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, the authors present RT-PCR data that shows no decrease in transcription of synaptic proteins in unc-104 mutants as predicted by their model.

Other major concerns:

1\) Much of the wnd, unc-104 interaction data was obtained using a previously published hypomorphic alleles of unc-104. Given their central role in this work, the authors should provide some information on the nature of these alleles. In the analysis of interactions between null mutants presented in [Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}, it is important to include an analysis of wnd mutants alone (as in 6C-G) to rule out additive effects. Have the authors analyzed dominant suppression of unc-104 phenotypes by wnd, which would strongly support the conclusion that the two genes function in a linear pathway?

2\) An electrophysiological analysis was conducted in hiw mutants (where Wnd levels are increased), but should be completed in wnd overexpression lines to more directly test the hypothesis that increased Wnd explains functional defects in unc-104 mutants. Here, the authors present the surprising result that wnd suppresses the physiological defect in hiw mutants. This is in contrast to results published in an earlier paper with overlapping authors (Collins et al., 2006). They suggest the difference may be due to the use of different wnd alleles, but this needs to be addressed experimentally given the importance of wnd suppression phenotypes to this work and the high impact of the previously published result that is called into question.

3\) Given that synaptic function is fully suppressed in hypomorphs, it is surprising that locomotion and viability show little improvement. This disconnect should be further addressed by evaluating the relevant allelic combinations, not just RNAi. Relatedly, how is there so much movement in double null mutants ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) when there is essentially no SV transport to AZs?

4\) It was cumbersome to parse through the data as presented in 21 figures (9 main plus 12 supplemental) including 2 separate model figures. [Figure 6E](#fig6){ref-type="fig"} was presented in a way that made it especially difficult to compare genotypes. It also looks like the effect of wnd loss of function on Brp levels is very different between [Figures 1F](#fig1){ref-type="fig"} (no effect) and 4G (nearly doubled).

*Reviewer \#2:*

In \"The Wallenda/DLK kinase restrains the expression of pre-synaptic proteins according to their Transport\" Drs. Collins, Rasse and colleagues reveal an unexpected novel role for Unc-104 in regulating synaptic development and bouton composition in a manner not directly related to its long-range transport functions.

Synaptic vesicle precursor proteins and active zone proteins are synthesized in neuronal cell bodies and transported to synapses. Kinesin motors (Unc-104) transport SV precursors. AZ components are reduced at the synaptic terminals of the unc-104 mutants, but their transport has never been shown to be driven directly by unc-104. Through an exhaustive set of experiments (using diverse mutant and RNAi combinations), the authors show that defects in unc-104 lead to the activation of the Wnd signaling pathway (via Bsk and Fos), which in a cell-autonomous manner regulates AZ protein levels in neuronal cell bodies and synaptic terminals. Suppressing Wnd signaling in unc-104 strong hypomorphs or in RNAi knockdowns significantly reduces the defects in AZ at the synapse, defects in synaptic transmission, larval mobility and viability, but only partly rescues SV protein levels. Furthermore, puckered expression and axonal regeneration, both of which require enhanced Wnd signaling, are enhanced in unc-104 mutants.

Crucially, through genetic interaction studies with null mutants of unc-104 (as opposed to hypomorphs) the authors revealed two separable functions for unc-104: one for trafficking SV associated proteins to the synapse (VGlut1, Syt1, Csp) and one for activating the Wnd pathway, which in unc-104 mutants lead to the decrease of multiple synaptic proteins.

While these represent important, transformative, and convincing advances in our understanding of unc-104 and Wnd/DLK signaling in synapse formation, the one weakness of the paper is that it does not uncover HOW Unc-104 regulates Wnd signaling, or how Wnd signaling constrains synaptic protein levels. Filling this gap is likely beyond the scope of the current work and not necessary to merit publication in *eLife*, but there are several points that the authors could address based on their current approaches:

1\) It is important for the authors to quantify Wnd-MiMIC levels in the neuronal cell bodies (akin to the way they quantified UAS-WnkKD in supplemental [Figure 1](#fig1){ref-type="fig"} to [Figure 8](#fig8){ref-type="fig"}). They should also explain why they used the kinase dead version and whether they believe it behaves differently from wild type Wnd.

2\) The authors present hiw data but do not address hiw function in their model or discussion. The authors should measure hiw RNA and/or protein levels in Unc-104 mutants to ask if hiw is contributing to the phenotype. If hiw protein (but not RNA) is downregulated in the unc-104 mutant, it might suggest that autophagy-mediated degradation of Hiw (as per Shen et al., 2009), and perhaps other synaptic proteins, underlies the regulatory mechanism by which unc-104 constrains synaptic protein levels in response to cell body accumulation of cargo. This could be simply tested by evaluating the amount and distribution of an autophagy flux marker such as ATG8-GFP-mCherry.

3\) The observation that ectopic overexpression of Brp, SytI and VGlut leads to increased puc-lacZ reporter signal begs the question whether this also triggers changes in Wnd (or hiw) levels or localization, as these results could provide more insight into the mechanism via which Unc-104 deficits lead to Wnd activation.

*Reviewer \#3:*

This paper describes a genetic interaction between the Unc-104 motor protein and the Wnd DLK kinase. The authors presented impressive amount of data from synapse cell biology to physiology with an attempt to conclude that Wnd activation is sensitive to disruption of unc-104 mediated transport of some axonal components. The measurement for Wnd activity mostly relied on induction of a puc-LacZ reporter in the soma, and morphological changes of NMJ terminals. While experiments are generally carefully done, individual experiment serves the purpose of supporting the genetic interaction. However, as a whole, the paper feels like a catalog of correlative connections, missing conceptual depth. A consistent term used throughout the paper is \"modest effect\" or \"modest role\", suggesting ambiguity of the observations and the conclusions. Some of the issues could be addressed by re-writing, others need additional data.

Their observation that Wnd suppresses the lethality of unc-104 mutants is the key observation led to this study. But it is not clear whether this suppression is directly caused at the level of presynaptic transport. Does inhibition of Wnd downstream factors, *JNK* and FOS, also suppress unc-104 lethality? In subsection "Wnd inhibits synapse assembly independently of cargo transport downstream of Unc-104" the final sentence of the second paragraph seems to state that \"most or all\" unc-104; wnd mutants actually die. Is the suppression of lethality rather minor?

In axon regeneration analysis in unc-104 mutants, the observed effects should be rescued using wild type unc-104.

Subsection "Activation of the Wnd signaling pathway in neurons is sufficient to impair presynaptic structure and synaptic transmission": first paragraph, the authors state \"ectopic activation of Wnd should mimic the unc-104 mutant phenotypes\". But where is Wnd normally activated?

In the same section, second paragraph: The authors made a comment about the result in [Figure 4D-F](#fig4){ref-type="fig"} being differed from their previous study that used a hypomorphic allele of Wnd\". They should perform the same analysis in parallel on both null and that hypomorphic allele.

They talked about similarities of how loss of Hiw or of Unc-104 affect Wnd function. An important experiment should include a double mutant study of Hiw and unc-104.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for choosing to send your work entitled \"The Wallenda/DLK kinase restrains the expression of pre-synaptic proteins according to their transport\" for consideration at *eLife*. Your letter of appeal has been considered by a Senior Editor in discussion with the reviewers, and we are prepared to consider a revised submission with no guarantees of acceptance.

While we are happy to consider a revised manuscript, you will see that we have some serious concerns that need careful attention. We see merit in the author\'s rebuttal letter that the most concerns can be addressed with rewriting and some additional experiments and key issues addressed. The overall impact of the work, if these points are well-addressed, can be strong, since it provides a fundamentally new model for how unc-104 contributes to neuronal function, by activating an axonal injury pathway. However, the data and model also need to be explained more clearly to be digestible by a broad readership such as at *eLife*.

In response to the concerns raised about inconsistent results in their wnd loss-of-function analysis, the authors are dismissive, imploring us to \"Note that our model is NOT that Wnd functions as a major restraint on these proteins during normal conditions or during development,\" yet their subheading describing these results is \"Wnd restrains the expression of presynaptic proteins at early stages of synaptogenesis.\" In a second example, the authors dismiss concerns about their analysis of MiMIC-GFP instead of endogenous Wnd levels by simply stating that the Wnd antibody does not work well for immunohistochemistry without addressing the fact that they have previously published analogous experiments using their Wnd antibody for immunohistochemistry (Collins et al., 2006). The authors may want to pay particular attention to these points.

The authors should measure puc-LacZ expression in additional unc-104 mutants. Also, rescue of additional phenotypes aside from NMJ morphology and active zone apposition to PSD (e.g. lethality or synaptic function) by BSK and FOS would provide strong support for the model. However, I was not concerned that the Mimic tool showed an increase in Wnd while the western blot did not, since the Mimic tool accounts for changes in subcellular distribution -- this point can be addressed better by the authors in the manuscript. However, it is absolutely essential that the MIMIC phenotype be quantified and use of the Kinase Dead explained in the text.

The effect of wnd on the timing and expression of presynaptic proteins needs to be much more clearly explained, as discussed in the rebuttal. As it stands this section is very distracting and confusing. The authors should also clarify their model for how synaptic protein levels are regulated in the unc-104 mutants (though the authors do discuss the RT-PCR data and I agree with them that RT-PCR detects transcripts from all the cell types in all the tissues used for the mRNA prep, and does not account for specific defects in protein levels and localization at the neuronal cell bodies and synaptic terminals). The main point of the paper does not hinge on a particular model of synaptic protein level control, but the authors do need to clarify their explanations, either in the text or with more experiments.

Wnd null mutants alone should be included in [Figure 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"} for comparison in this specific assay. However, though phenotypes in transheterozygotes can be informative, lack of a dominant transheterozygote phenotype might just reflect gene dose requirements, and so we did not put as much weight on that particular experiment.

Electrophysiological analysis (and synaptic vesicle protein levels) in wnd overexpression lines would provide strong corroboration that increased Wnd explains functional defects in unc-104 mutants. Addressing the discrepancy with previous results (Collins 2006) on Wnd suppression of the hiw phenotype will be also be important.

On the other hand, experiments to address the cellular function of hiw would be nice but are not essential to the main interesting points of the paper. If the authors have the data or a more clear model of the role of hiw, it would be helpful to include, but we don\'t think it\'s necessary.

The rescue of the axon regrowth phenotype are not critical for the main conclusions of the paper and could take a lot of time.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by K VijayRaghavan as the Senior Editor and the Reviewing Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

As you can see your manuscript needs only a few minor points that need to be addressed. Please do that speedily. We can then accept the revised manuscript after an editorial examination.

*Reviewer \#1:*

In their revised manuscript, the authors have been very responsive to reviewer suggestions. The logical flow of the manuscript is significantly improved and experimental concerns directly addressed.

I have one question regarding the addition of wnd null data to [Figure 1](#fig1){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. Is it still accurate to state that \"Control and Experimental animals were always dissected, fixed and stained in the same dish/slide and imaged in parallel using identical confocal settings\" (Experimental Procedures,), or were the new data obtained in separate experiments and normalized to wild type for incorporation with previously obtained data?

*Reviewer \#2:*

The manuscript is much improved with the suggested experiments, reorganization, and rewriting. My concerns have been adequately addressed and I think that this is a very interesting, well-executed, and thought-provoking study.

10.7554/eLife.24271.032

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

Reviewer \#1:

> Li et al. present work investigating Wnd/DLK MAP kinase pathway regulation of expression levels of synaptic genes following disrupted axonal trafficking upon knockdown of Unc-104/Kif1a, a Kinesin 3 motor, and during development. Based on the exciting finding that loss of wnd suppresses the reduced presynaptic active zone (AZ) protein accumulation and associated functional deficits of unc-104 hypomorphic mutants, the authors propose a model in which the Wnd pathway \'senses\' levels of presynaptic proteins in the cell body and acts as a brake on expression when levels exceed the ability of the cell to transport these proteins to synapses. While this is an interesting model, it is not fully supported by the data presented as detailed below.

We appreciate that the reviewer recognizes the novelty and strength of our findings and the model we propose. With a careful and much appreciated eye on the data, the reviewer summarizes below some concerns about individual observations. We are optimistic that our explanations and clarifications described here, along with some adjustments and clarifications in the writing, can resolve this reviewer's concerns.

> 1\) Support for their model:
>
> A\) The authors propose that unc-104 function can be divided into a transport role for SVs that is independent of Wnd and a Wnd/DLK pathway-dependent role in regulating AZ proteins.

This statement is not precise for what we propose. Please see the clarifications below.

> The differentiation between Brp and SV proteins is based on the finding that reduced synaptic levels of Brp in unc-104 nulls are suppressed by wnd but SV protein levels are not, in contrast to their findings in unc-104 hypomorphs.

To clarify, in *unc-104; wnd* double mutants compared to *unc-104* mutants alone, we see a major increase in total levels (across the sum of the cell body, axon and synaptic compartments) for *both* AZ and SV proteins. This is evident for both *unc-104-*hypomorph ([Figure 6 C-E](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} C) and null mutations ([Figure 5A-E](#fig5){ref-type="fig"}, [6A-B](#fig6){ref-type="fig"}, & [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} A-B). These observations lead to our major interpretation that the Wnd pathway, which becomes activated in *all of the unc-104 mutants*, down-regulates the levels of *both AZ and SV* proteins.

> Simpler models should be considered. For example, the observation that wnd suppresses the loss of SV proteins at synapses in hypomorphs with residual Unc-104 activity but not nulls is more easily explained by the model that SV transport, but not Brp transport, is fully dependent on Unc-104, consistent with prior observations in Drosophila (Pack-Chung et al., 2007).

This explanation is indeed incorporated within our model ([Figure 9](#fig9){ref-type="fig"}). This explanation accounts for the suppression of AZ but not SV localization in the *unc-104* mutants. However it is not the full picture, since this explanation does not account buildup of both AZ and SV components in the cell bodies of *unc-104-null; wnd* and *unc-104-hypomorph;wnd* double mutants ([Figure 6](#fig6){ref-type="fig"}).

The most important part of the model is that the Wnd pathway, which becomes activated when unc-104 function is lost, promotes a decrease the total cellular levels of many AZ and SV proteins. This effect is an important element of the synaptic phenotypes in both *unc-104-hypomorph* and *null* mutants. Our findings with *unc-104-null* mutants in [Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"} show that this effect for Wnd signaling can be genetically and mechanistically separated from a transport role of Unc-104.

We originally interpreted that the reviewer may be cautioning us to be careful about implying precise motor-cargo relationships. It is indeed possible that Unc-104 plays some partial role in AZ localization -- we simply need to be precise in our language. However our primary point is not about which motor carries which cargo. Instead, our findings explicitly reveal the pitfalls to interpreting motor cargo relationships from standard phenotypic analysis. Our finding that an axonal injury pathway is activated in *unc-104* mutants provides a new view with alternative interpretations for other published studies in the field. Several relevant previous observations along with the exciting implications are discussed in Discussion section.

> B\) The strongest evidence for activation of Wnd in Unc-104 mutants comes from the puc-LacZ experiments in unc-104 RNAi lines ([Figure 3B](#fig3){ref-type="fig"}). Given the importance of this finding, it this experiment should be conducted in unc-104 null and hypomorphic mutants.

We agree that evidence for Wnd's activation in the *unc-104* mutants is an important part of the paper. We show this for two independent RNAi lines, which show similar phenotypes to the multiple hypomorphic alleles (*bris* and *O3.1*) used in this paper across other assays. The suggestion to show this for additional alleles is do-able. We already have *puc*-lacZ combined into *unc-104*-hypomorph lines so we think it would be straight-forward to include this additional data.

Importantly, we already present additional support that the Wnd pathway is activated. In *unc-104-hypomorph* mutant and RNAi lines we see synaptic over-branching phenotypes that are hallmark of Wnd activation, and these are dependent upon Wnd and downstream *JNK* and Fos signaling components ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}, and also data not shown). We are thinking to move this data to the main part of [Figure 3](#fig3){ref-type="fig"} instead of supplemental data for the revision.

We also show in hypmorph/null mutants that Wnd protein is physically altered in levels and localization by immunohistochemistry using two independent reagents: the GFP-tagged MiMIC-Wnd line ([Figure 8](#fig8){ref-type="fig"}) which tags endogenous Wnd with GFP, and also for transgenically expressed GFP-Wnd-KD ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), which has been used in previous studies of Wnd's regulation (Collins et al., 2006; Xiong et al., 2010; Yan et al., 2016).

And finally, our epistasis experiments with *unc-104* mutants suggests strongly that the Wnd pathway is responsible for synaptic phenotypes in *unc-104* mutants, hence functions downstream. This analysis in late-staged embryos is technically challenging -- only a few labs in the world can do it and it represents 9 months of effort on our part. The results were important for reaching an understanding of the relationship.

> It\'s not clear how the proposed model leads to the specificity for unc-104 reported here. Have the authors investigated if cell body levels of presynaptic proteins are increased in these other mutants?

We see cell body accumulations of presynaptic proteins in multiple hypomorph and null *unc-104* mutant combinations ([Figure 6](#fig6){ref-type="fig"}: *bris/P350* and *P350/P350*; Unpublished: *bris/d11204; o3.1/P350; 170/170; 52/52*), and also for *unc-104* RNAi knockdown in neurons (pan-motoneurons, using OK6-Gal4 or single motoneuron, using m12-Gal4). More importantly, under all these different conditions, when activation of the Wnd signaling is reversed/suppressed via wnd RNAi-knockdown or in *wnd, unc-104* double mutants, the cell body accumulation is dramatically enhanced.

Upon reviewing the manuscript after reading the reviewer's queries, we realize it would be helpful to provide more background information about the different 'hypomorph' alleles, and clarify/explain in more detail how all of the alleles show similar synaptic phenotypes and relationships with Wnd to that of simple knock-down of Unc-104 with RNAi.

In contrast to the multiple mutations that reduce Unc-104 function, mutations that impair kinesin-1 function show accumulations of presynaptic proteins within segmental nerves rather than in the cell bodies, and also do not significantly induce the puc-lacZ reporter ([Figure 3B](#fig3){ref-type="fig"}).

> In [Figure 8](#fig8){ref-type="fig"}, the authors show that GFP-tagged Wnd MiMIC lines show increased Wnd in unc-104 mutants when well-characterized antibodies to Wnd (Collins et al., 2006) fail to show an increase. If they are going to include this data, the authors should provide an explanation for why the MiMIC data might provide a better indication of the underlying biology.

To examine Wnd protein levels, we employed multiple approaches ([Figure 8](#fig8){ref-type="fig"}). The Wnd antibody works great for Western Blots but not well for immunohistochemistry. The GFP epitope within the MiMIC-GFP-Wnd line allows for some detection by immunohistochemistry (which we show controls for here), hence an examination of protein localization. We were not able to detect a global increase in the levels of Wnd protein within brain extracts by Western Blot, but we were able to see changes in the enrichment of MiMIC-GFP-Wnd in cell bodies (but not in axons and synapses). In addition, we observe changes in the levels and localization of transgenically expressed GFP-Wnd-KD ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), which has been used in previous studies of Wnd's regulation (Collins et al., 2006; Xiong et al., 2010; Yan et al., 2016).

The observation that a global increase in endogenous Wnd levels was not detected by Western Blot may benefit from some further clarification and discussion. The Western Blots are necessarily carried out with extracts made from dissected larval CNS/brains, pooled in entirety. We cannot isolate individual neurons for this analysis. We've observed that the activation of Wnd and the regulation of presynaptic proteins by Wnd appears most striking in motoneurons. The potential specificity to motoneurons makes it harder to detect simple biochemical evidence for the relationship using standard biochemical methods from whole larval brains.

> C\) The evidence that Wnd regulates the levels of presynaptic protein levels and in particular that it acts at the level of transcription is somewhat inconsistent. Upon Wnd overexpression, the authors observed decreased protein levels at active zones as predicted. However, in wnd null embryos they see increased levels in some proteins at some stages, but decreases in other proteins (e.g., Brp). This and the absence of a consistent effect on the timing or expression, weakens their conclusion that wnd controls the levels and timing of expression of AZ and SV components.

An important but overlooked point here is that Wnd signaling is normally highly restrained in wild type, uninjured animals. If its role is primarily to respond to injury or stress, then it is expected that *loss-of-function* phenotypes in an uninjured background should be mild. With an original motivation to understand whether there is also a role for Wnd during normal synaptic development, we examined these phenotypes carefully during development. We found that the *wnd loss-of-function* phenotypes are indeed mild. However, strikingly, we did notice some elevation in VGlut and Syt protein co-incident with the onset of expression for these proteins. Note that our model is NOT that Wnd functions as a major restraint on these proteins during normal conditions or during development. Rather, Wnd restrains these proteins when it is substantially activated. In normal conditions this may occur only at extremely low levels to keep total synaptic protein levels in balance.

The fact that we did not observe an increase in Brp does not negate the model. Very little is currently known about how the expression of AZ and SV proteins are regulated developmentally --this is an interesting topic for future studies. It is likely that multiple mechanisms exist for different proteins, and that Brp levels are not sufficiently high during these stages of normal development to detect a role for Wnd in uninjured animals.

> In [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, the authors present RT-PCR data that shows no decrease in transcription of synaptic proteins in unc-104 mutants as predicted by their model.

As discussed above for point B, studies with whole brain extracts (for Western Blot or RT-PCR analysis, referenced here) are likely to miss the cell specific regulation which is occurring in motoneurons. It is a future direction to profile the responses in motoneurons specificially. This requires some additional technical innovations since cell sorting causes axotomy, which activates the Wnd pathway on its own.

> Other major concerns:
>
> 1\) Much of the wnd, unc-104 interaction data was obtained using a previously published hypomorphic alleles of unc-104. Given their central role in this work, the authors should provide some information on the nature of these alleles.

We agree and can provide further clarification in the text. An important clarification point is that we see similar suppression by *wnd* mutants for multiple hypomorphic allele combinations of *unc-104* mutants (See point B above and subsection "The Wnd signaling pathway mediates presynaptic defects in unc-104 mutants"), and also when Unc-104 protein levels are simply reduced by RNAi-knockdown. So we think that any manipulation that impairs Unc-104's basic function leads to activation of Wnd signaling.

> In the analysis of interactions between null mutants presented in [Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}, it is important to include an analysis of wnd mutants alone (as in 6C-G) to rule out additive effects.

We have indeed included detailed analysis of *wnd* mutants alone at the embryonic stages in [Figure 7](#fig7){ref-type="fig"}. We should be able to include for reference some of the relevant data [Figure 6A,B](#fig6){ref-type="fig"} for comparison.

> Have the authors analyzed dominant suppression of unc-104 phenotypes by wnd, which would strongly support the conclusion that the two genes function in a linear pathway?

We've observed that partial knockdown of Wnd signaling by RNAi can suppress *unc-104* phenotypes (Figure 1---figure supplement 1B). We feel that experiments with *wnd* heterozyogotes would not really add much more to this paper, especially since it is not clear in our data that removal of one copy of *wnd* leads to a 50% reduction of Wnd levels in all cell types.

The reviewer may instead be referring to double-heterozygote experiments, which can be helpful for revealing relationships in a linear pathway via their sensitivity to gene dosage of both factors. This kind of analysis is more do-able when both genes have similar loss-of-function phenotypes. However *unc-104* and *wnd* mutants have opposite *loss-of-function* phenotypes, so we're not sure what we would learn from a double heterozygote.

> 2\) An electrophysiological analysis was conducted in hiw mutants (where Wnd levels are increased), but should be completed in wnd overexpression lines to more directly test the hypothesis that increased Wnd explains functional defects in unc-104 mutants. Here, the authors present the surprising result that wnd suppresses the physiological defect in hiw mutants. This is in contrast to results published in an earlier paper with overlapping authors (Collins et al., 2006). They suggest the difference may be due to the use of different wnd alleles, but this needs to be addressed experimentally given the importance of wnd suppression phenotypes to this work and the high impact of the previously published result that is called into question.

The main point to communicate in [Figure 4](#fig4){ref-type="fig"} is that ectopic activation of Wnd alone is sufficient to induce defects in synapse structure and function. We think that the suggested physiology characterization for *wnd* over-expression could further and more simply support this point. These experiments should be complete-able in a relatively short time frame, so we will aim to add this data to the revised manuscript. If we can indeed include this data, then we may then want to move the *hiw* data to supplemental data, where the partial differences with the 2006 study are less distracting.

While *hiw* mutants (and *unc-104* mutants) show mild reductions in quantal content, they are significantly reduced for mini frequency. The observation that *wnd* mutations suppress *hiw*'s defect in mini frequency are actually conserved between both our observations and the previous 2006 study. The single difference is that the 2006 study did not reveal a suppression of the defect in quantal content, while ours does. We would indeed like to understand this better -- resolving the differences will require repeating exactly the same allele combinations in our own conditions for comparison. This is do-able and we are willing to do it. The main point of this would be to provide further context for previous observations in the field rather than to further validate the observations we have made here in this paper (which we see for two allelic combinations and are consistent with the morphological data).

> 3\) Given that synaptic function is fully suppressed in hypomorphs, it is surprising that locomotion and viability show little improvement. This disconnect should be further addressed by evaluating the relevant allelic combinations, not just RNAi. Relatedly, how is there so much movement in double null mutants ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) when there is essentially no SV transport to AZs?

Actually, neither of these results are surprising.

Our study indicates that the effects of Wnd signaling (which is activated in *unc-104* mutants and is responsible for many interesting synaptic phenotypes) are separable from a primary function for Unc-104 in transporting SVs ([Figure 5](#fig5){ref-type="fig"}). In addition, Unc-104/KIF1A has many other proposed roles, including regulation of autophagy (Stavoe et al., 2016), lysosome transport (Guardia et al., 2016), insulin secretion (Cao et al., 2014), and cell migration (Carabalona et al., 2016). It would be presumptuous to assume or expect that we could completely rescue lethality in these animals, which are quite defective in many aspects. Likewise for locomotion: while we see strong phenotypes at the NMJ synapse, this is not the only synapse that animals need for locomotion. It is remarkable that we see ANY improvement in locomotion and viability.

For the *unc-104-null* mutants, the rescue is also extremely mild and we state this in the text (Subsection "Wnd inhibits synapse assembly independently of cargo transport downstream of Unc-104"). Perhaps the strong difference in bar graphs in [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"} give an impression there is a stronger suppression. However note that this is simply the "percentage of animals showing muscle movement" not the actual 'degree' of movement, and the movement is observed only immediately after the animals hatch. They die soon thereafter.

We worry based on these points and also the summary statement that these 'modest' or 'inconsistent' effects upon lethality and motility were a primary criticism for the paper. Therefore it is important to clarify that these effects are consistent with the model we present in the paper (if they were stronger they would actually argue against it). The 'modest' rescue of lethality should not diminish the importance of our findings, which identify specific cellular roles for Wnd in *unc-104* mutants.

> 4\) It was cumbersome to parse through the data as presented in 21 figures (9 main plus 12 supplemental) including 2 separate model figures.

We appreciate the efforts from the reviewer to evaluate all of the data, and their feedback has helped us see how we might be able to improve the writing to make the paper less cumbersome to read. It has been over 7 years of hard efforts between our two labs to reach our current understanding of the surprising relationship between Unc-104 and Wnd. There are many more data that are not included in this paper. We will work further on the writing to better communicate how the individual experiments build upon one another to fit into the big picture story.

> [Figure 6E](#fig6){ref-type="fig"} was presented in a way that made it especially difficult to compare genotypes.

We appreciate this point. It is important to consider the levels in the different cellular compartments and to assess differences in total levels accounting for all of the compartments. This comparison is our goal for [Figure 6E](#fig6){ref-type="fig"}. If one examines synaptic levels alone (in [Figure 1F](#fig1){ref-type="fig"}), that is only part of the story.

> It also looks like the effect of wnd loss of function on Brp levels is very different between [Figures 1F](#fig1){ref-type="fig"} (no effect) and 4G (nearly doubled).

The *wnd* mutants in [Figure 1F](#fig1){ref-type="fig"} (1.4 fold) and 4G (2 fold) are slightly different in genotype and strain background (*wnd^3/3^* and *wnd^3/df^,* respectively). Since the *wnd^3/3^* animals are maintained in the same strain background there is a chance to accumulate genetic modifiers of the phenotype in the background. We prefer to carry out all of our studies with two different alleles crossed to one another to be certain the phenotype is indeed due to the mutation we are manipulating.

Reviewer \#2:

> \[...\] While these represent important, transformative, and convincing advances in our understanding of unc-104 and Wnd/DLK signaling in synapse formation, the one weakness of the paper is that it does not uncover HOW Unc-104 regulates Wnd signaling, or how Wnd signaling constrains synaptic protein levels. Filling this gap is likely beyond the scope of the current work and not necessary to merit publication in eLife, but there are several points that the authors could address based on their current approaches:

We are glad that reviewer 2 shares the same point of view with us in both strengths and one weakness. We also agree that this weakness is beyond the scope and not necessary for our current work to be published. The reviewer's suggestions listed below are fair and we are ready to address all of these points.

> 1\) It is important for the authors to quantify Wnd-MiMIC levels in the neuronal cell bodies (akin to the way they quantified UAS-WnkKD in supplemental [Figure 1](#fig1){ref-type="fig"} to [Figure 8](#fig8){ref-type="fig"}). They should also explain why they used the kinase dead version and whether they believe it behaves differently from wild type Wnd.

The quantification of Wnd-MiMIC levels can certainly be included in the revised manuscript. Ectopic expression of Wnd (lacking the kinase mutation) leads to lethality and technical complications. We can also add additional information about the Wnd-kinase-dead (KD) transgene, which has been used in previous studies to uncover biologically important mechanisms of regulation (Collins et al., 2006; Xiong et al., 2010; Yan et al., 2016). See also our discussion to reviewer 1's point B, above.

> 2\) The authors present hiw data but do not address hiw function in their model or discussion. The authors should measure hiw RNA and/or protein levels in Unc-104 mutants to ask if hiw is contributing to the phenotype. If hiw protein (but not RNA) is downregulated in the unc-104 mutant, it might suggest that autophagy-mediated degradation of Hiw (as per Shen et al., 2009), and perhaps other synaptic proteins, underlies the regulatory mechanism by which unc-104 constrains synaptic protein levels in response to cell body accumulation of cargo. This could be simply tested by evaluating the amount and distribution of an autophagy flux marker such as ATG8-GFP-mCherry.

These interesting suggestions center around the goal of understanding whether Hiw, a major known regulator of Wnd, plays a role in Wnd's activation in *unc-104* mutants. Based on several observations thus far (some in the manuscript and some yet unpublished), we think that loss of Hiw function is unlikely to explain or mediate the activation of Wnd in *unc-104* mutants.

1\) The effects of *hiw* and *unc-104* mutants upon the levels and localization of Wnd are strikingly different: in *hiw* mutants, the levels of Wnd are strongly elevated throughout the animal and this elevated Wnd protein is observed to localizes to synapses and neuropil (Collins et al., 2006, and also [Figure 8B](#fig8){ref-type="fig"}). In contrast, *unc-104* mutants cause more modest changes to Wnd protein and levels, and these changes are only observed in cell bodies, not synapses ([Figure 8](#fig8){ref-type="fig"} and supplements).

*2) hiw* mutants show a strong delay in axonal degeneration (Xiong et al., 2012; Babetto et al., 2013). However we found no delay to degeneration in *unc-104* mutants (unpublished).

3\) Western blot results did not show an obvious reduction in Hiw protein level when *unc-104* is knocked down (unpublished).

The potential role of autophagy is an interesting topic to further understand. Thus far we have found that null mutations in *atg7* and knock-down of atg13 or Fip200 in neurons, which are critical for different stages of autophagy (Fougeray and Pallet, 2015), did not alter Wnd signaling using *puc*-lacZ as a reporter (unpublished). This runs a bit counter to predications suggested by the Shen et al., 2009 study. So more needs to be done to sort this out and this is a topic for future work.

> 3\) The observation that ectopic overexpression of Brp, SytI and VGlut leads to increased puc-lacZ reporter signal begs the question whether this also triggers changes in Wnd (or hiw) levels or localization, as these results could provide more insight into the mechanism via which Unc-104 deficits lead to Wnd activation.

This is a good suggestion but a negative or mild result could occur simply because the effect of overexpressing a single pre-synaptic protein does not activate the pathway to the same extent, so would not be useful in ruling out a model. We appreciate that the reviewer acknowledges that filling the gap of HOW Unc-104 regulates Wnd signaling 'is likely beyond the scope of the current work and not necessary to merit publication in *eLife*'. We have some additional ideas on this question that we want to carry out in future studies.

Reviewer \#3:

> This paper describes a genetic interaction between the Unc-104 motor protein and the Wnd DLK kinase. The authors presented impressive amount of data from synapse cell biology to physiology with an attempt to conclude that Wnd activation is sensitive to disruption of unc-104 mediated transport of some axonal components.

This statement reflects some confusion between our major conclusions in the paper with models and ideas that we raise. We propose an idea that Wnd pathway activation is sensitive to build-up of Unc-104's cargos. However this is the speculative idea in the paper, which is framed as a model for thinking about the data as a whole, combined with other observations in the field. It is not the primary goal of the paper to reach this idea as a 'conclusion'.

> The measurement for Wnd activity mostly relied on induction of a puc-LacZ reporter in the soma, and morphological changes of NMJ terminals.

In addition we showed an induction of Wnd protein levels and localization in motoneurons using two independent reagents/methods (endogenous MiMIC-tagged Wnd ([Figure 8B-C](#fig8){ref-type="fig"}) and ectopically expressed GFP-Wnd ([Figure 8---figure supplement 1B-D](#fig8s1){ref-type="fig"}), and extensive genetic interactions ([Figures 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"} with accompanying supplements). Importantly, the genetic interactions include suppression of NMJ phenotypes in *unc-104* null mutants ([Figure 5](#fig5){ref-type="fig"} and accompanying supplement), which suggests that Wnd functions downstream of Unc-104 to mediate major aspects of the synaptic phenotype. Please also see our discussion for reviewer 1 point B.

> While experiments are generally carefully done, individual experiment serves the purpose of supporting the genetic interaction. However, as a whole, the paper feels like a catalog of correlative connections, missing conceptual depth. A consistent term used throughout the paper is \"modest effect\" or \"modest role\", suggesting ambiguity of the observations and the conclusions. Some of the issues could be addressed by re-writing, others need additional data.

This paragraph is also used in the summary statement. However the point that "the paper feels like a catalog of correlative connections, missing conceptual depth" is not well explained with sufficient points for us to understand how this conclusion is reached. The actual itemized points for this reviewer (as we discuss below) and the other reviews (as discussed above) are all readily addressable, and do not detract from the major conclusions and impact of this paper.

While the genetic interaction between Unc-104 and Wnd is very strong, there are indeed several results in the paper that show "modest" effects, and we also presented several negative data. However all of these data are helpful for reaching our understanding of the relationship between Unc-104 and Wnd. Importantly, all of these "modest" effects are consistent with the model we propose, and none are essential for the primary conclusions of the paper. Reasons for "modest effects are discussed in points C and 3 from reviewer 1. Due to the misunderstandings reflected in the comments, we plan in revision to do a better job with the writing to make these reasons clear up front, so that is easier for readers to follow the expectations for individual experiments and how they build upon one another.

> Their observation that Wnd suppresses the lethality of unc-104 mutants is the key observation led to this study. But it is not clear whether this suppression is directly caused at the level of presynaptic transport. Does inhibition of Wnd downstream factors, JNK and FOS, also suppress unc-104 lethality? In subsection "Wnd inhibits synapse assembly independently of cargo transport downstream of Unc-104" the final sentence of the second paragraph seems to state that \"most or all\" unc-104; wnd mutants actually die. Is the suppression of lethality rather minor?

There is a significant misunderstanding here: the suppression of lethality data is NOT a 'key observation' in this study! Instead, the key observations that led to and are fundamental to our study are the striking suppression of synaptic phenotypes (for which we have extensive data in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, supplemental data and additional data not shown). We show in this paper specific cellular phenotypes that are mediated by Wnd, which provide a richer depth of information than is possible with simple lethality data.

The suppression of lethality is indeed only partial and this makes sense with the model we have reached. As we have detailed above in the discussion for reviewer 1's point 3, the genetic data with *unc-104* null mutants tells us that while activated Wnd signaling is responsible for many of the synaptic phenotypes of *unc-104* mutants, this is separate from other important transport functions of Unc-104,

We suspect that some confusion about the expectations for the lethality data along with some confusion about its extent expressed by reviewer 1 may have distracted the reviewers' discussion to result in the ultimately negative conclusion for this paper. With these points clarified we think the reviewers may reach a different conclusion.

> In axon regeneration analysis in unc-104 mutants, the observed effects should be rescued using wild type unc-104.

While this experiment is do-able, it would not add much to the paper. We included the enhanced regeneration as further evidence that the Wnd pathway is activated in *unc-104* mutants. However we already have other data that more directly shows this point, so we could simply remove this data without impacting our conclusions for this paper. It may still be useful for the field have the regeneration data included for information that it may add to other published studies. For instance, a recent study from the Colon-Ramos lab (Stavoe et al., 2016) suggested that *unc-104* mutants show enhanced axonal outgrowth phenotypes in *C. elegans* PVD neurons. This may be consistent with the enhanced axonal regeneration phenotype we have observed here. However, because this is not essential data for the conclusions of our study, we hope the reviewers agree to go forward without the rescue data for the *unc-104* regeneration phenotype.

In the revision, we plan put the regeneration data into the supplemental data, and instead bring the synaptic overgrowth data from supplemental data ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) into the main text. The overgrowth data provide further support for the conclusion that Wnd signaling is activated in *unc-104* mutants.

> Subsection "Activation of the Wnd signaling pathway in neurons is sufficient to impair presynaptic structure and synaptic transmission": first paragraph, the authors state \"ectopic activation of Wnd should mimic the unc-104 mutant phenotypes\". But where is Wnd normally activated?

Please see our discussion above for reviewer 1's point C. All of our data, combined with other data in the field for Wnd/DLK function in flies and worms, suggest its activity is restrained to very low levels in 'normal' wild type uninjured animals. Most previous work in the field has focused on Wnd/DLK's role in injured neurons (when it is activated). There has previously been no supporting data (in flies or worms) to indicate that Wnd also functions in uninjured animals. In this present study we explored this question more deeply, through a careful analysis of *wnd loss-of-function* phenotypes during stages of embryonic development in [Figure 7](#fig7){ref-type="fig"}.

> In the same section, second paragraph: The authors made a comment about the result in [Figure 4D-F](#fig4){ref-type="fig"} being differed from their previous study that used a hypomorphic allele of Wnd\". They should perform the same analysis in parallel on both null and that hypomorphic allele.

Please refer to our discussion of this for reviewer 1's point 2 above. Importantly, and similarly to the other points, this point is addressable and is also not essential for the main conclusions of this paper.

> They talked about similarities of how loss of Hiw or of Unc-104 affect Wnd function. An important experiment should include a double mutant study of Hiw and unc-104.

We believe that this suggested experiment is to help in determining whether Hiw and Unc-104 regulate Wnd through the same or distinct pathways. However a consideration of the potential outcomes makes it unlikely that the experiment will yield new information. One would need to compare Wnd levels and localization in the *hiw; unc-104* double mutants to *hiw* and *unc-104* single mutants, which have very different phenotypes for both levels and localization. Because of the major transport defects in *unc-104* mutants, it is unlikely that Wnd localization and levels in the double mutant would resemble the *hiw* single mutant. Instead it is quite likely that one would observe increased levels of Wnd (due to loss of *hiw* function) AND an in increase in levels of Wnd in the cell body which occurs in the *unc-104* mutants. This kind of data would not help us distinguish whether Unc-104 and Hiw regulate Wnd through a common pathway or parallel pathways.

However to address the general question we could include some more discussion about potential relationships between Hiw and Unc-104. See our discussion for reviewer 2's point 2. However this relationship is a discussion point that is not essential for the major conclusions of this paper.

So, in summary for this point we respectfully disagree that analysis of the *hiw; unc-104* double mutant is an important experiment for this paper. Instead, it would be reasonable to include the discussion to reviewer 2's point 2 above in the published review and rebuttal section for *eLife*. This would be a great format for the field to see these additional points discussed, which are side-points for the main points of the paper.

\[Editors\' note: the author responses to the re-review follow.\]

> While we are happy to consider a revised manuscript, you will see that we have some serious concerns that need careful attention. We see merit in the author\'s rebuttal letter that the most concerns can be addressed with rewriting and some additional experiments and key issues addressed. The overall impact of the work, if these points are well-addressed, can be strong, since it provides a fundamentally new model for how unc-104 contributes to neuronal function, by activating an axonal injury pathway. However, the data and model also need to be explained more clearly to be digestible by a broad readership such as at eLife.

We appreciate the opportunity to address the points raised in the review. We have now provided the additional requested data, itemized below.

In addition, the questions raised in the first round of review helped us see how the writing and manuscript organization could be improved so that a broader audience could follow the narrative and the significance of our findings. To accomplish this we made changes in the order of data (Figure) presentation, and changes in text throughout the paper including the Abstract, Title, and Results. The accompanying 'track changes' version of the manuscript highlights the significant changes since the first version.

> In response to the concerns raised about inconsistent results in their wnd loss-of-function analysis, the authors are dismissive, imploring us to \"Note that our model is NOT that Wnd functions as a major restraint on these proteins during normal conditions or during development,\" yet their subheading describing these results is \"Wnd restrains the expression of presynaptic proteins at early stages of synaptogenesis.\"

We appreciate this point, and apologize that the previous attempt to explain our thinking came off as dismissive. In our revision we have worked to communicate our interpretation of results more carefully.

The principal finding in the paper is that Wnd signaling accounts for synaptic defects in *unc-104* mutants by down-regulating the expression levels of SV and AZ protein components. However this is a pathological context, in *unc-104* mutants. We wondered whether Wnd signaling ever plays a similar role in wild type animals.

Previous studies have suggested that while Wnd/DLK signaling becomes activated in injured neurons, it is normally highly restrained in uninjured animals (Collins et al., 2006; Xiong et al., 2010), and, in contrast to its essential role in responses to axonal injury, roles for Wnd in developmental axonal outgrowth or synapse formation have not been previously described (Collins et al., 2006). Importantly, the function of the Wnd signaling pathway had not previously been examined at the critical developmental stages of synapse formation, due to the technical challenges of dissecting late-stage embryos (whose diameter is approximately the size of two human hairs). The late-stage embryo dissection skills that we mastered for this project allowed us to probe this question carefully with the results presented in [Figure 8](#fig8){ref-type="fig"}.

Our findings (in [Figure 8](#fig8){ref-type="fig"}) indicate that the effects of *wnd* mutations upon SV protein expression are indeed modest in comparison to the dramatic effects of *wnd* in *unc-104* mutants. However they are nevertheless interesting to report since they suggest that Wnd signaling also restrains synaptic protein levels during development in wild type, uninjured animals.

According to the modified text, we changed the subheading of this section to "Wnd delays the expression of SV proteins during early stages of synapse development", and we have made large revisions in writing for this section.

> In a second example, the authors dismiss concerns about their analysis of MiMIC-GFP instead of endogenous Wnd levels by simply stating that the Wnd antibody does not work well for immunohistochemistry without addressing the fact that they have previously published analogous experiments using their Wnd antibody for immunohistochemistry (Collins et al., 2006). The authors may want to pay particular attention to these points.

As the reviewers pointed out, the Wnd antibodies developed in (Collins et al., 2006) could successfully detect a robust and Wnd-specific signal by both immunohistochemistry (IHC) and western blot (WB) in *hiw* mutants, when Wnd protein is elevated. However in wild type as well as *unc-104* mutant animals, we were unable to detect a reproducible IHC signal above background in our current conditions using these antibodies. While some misfortune may be potentially attributed to poor antibody storage conditions, we consider the difference between *hiw* mutants (in which a signal can be detected) and *unc-104* mutants (where we failed to detect an IHC signal) to be meaningful.

For the additional reagents used to examine Wnd protein, we have added some additional explanation into the manuscript text. That section is quoted here:

"We then looked further at Wnd's localization using available reagents. By immunocytochemistry (IHC) with anti-Wnd antibodies, Wnd protein remained below the detection threshold in both wild type and *unc-104* mutant animals (data not shown). \[...\] This highly expressed transgene also revealed an increase in cell body localized Wnd in *unc-104* mutants ([Figure 5D and F](#fig5){ref-type="fig"})."

> The authors should measure puc-LacZ expression in additional unc-104 mutants.

We have now included *puc*-lacZ measurements for additional *unc-104* alleles (*O3.1/170* and *bris/170*) in [Figure 4B](#fig4){ref-type="fig"}. All of the mutations tested (including the RNAi-knockdown, shown previously) lead to significant induction of *puc*-lacZ expression ([Figure 4B](#fig4){ref-type="fig"}).

> Also, rescue of additional phenotypes aside from NMJ morphology and active zone apposition to PSD (e.g. lethality or synaptic function) by BSK and FOS would provide strong support for the model.

We have added new electrophysiology data which shows that inhibition of downstream Wnd signaling components Fos or Bsk mimics *wnd* mutations in rescue of the severely impaired spontaneous synaptic release (mEJP frequency) in *unc-104* mutants ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). In addition, inhibition of Bsk rescued mEJP and EJP amplitude while inhibition of Fos rescued EJP amplitude and quantal content in the *unc-104* mutant background ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). These data add further support to the model that Wnd signaling mediates the synaptic transmission defects when Unc-104's transport is disrupted.

We also included additional data that inhibition of Fos and Bsk (*JNK*) also mimic *wnd* mutations in the accumulation of SV and AZ proteins in the cell body of *unc-104* mutants ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). These data further indicate that the signaling cascade downstream of Wnd promotes the restraint of presynaptic protein levels in *unc-104* mutants.

> However, I was not concerned that the Mimic tool showed an increase in Wnd while the western blot did not, since the Mimic tool accounts for changes in subcellular distribution -- this point can be addressed better by the authors in the manuscript. However, it is absolutely essential that the MIMIC phenotype be quantified and use of the Kinase Dead explained in the text.

We have added quantification for the changes noted for MiMIC-*wnd*-GFP ([Figure 5E](#fig5){ref-type="fig"}) and explanation of the GFP-*wnd-kinase dead* reagent in the text.

> The effect of wnd on the timing and expression of presynaptic proteins needs to be much more clearly explained, as discussed in the rebuttal. As it stands this section is very distracting and confusing.

We have done significant re-writing for this section to more clearly explain the rationale, expectations and interpretations of the study of *wnd loss-of-function* phenotypes during synaptic development ([Figure 8](#fig8){ref-type="fig"} and subsection "Wnd delays the expression of SV proteins during early stages of synapse development").

In addition, based on the original round of review, we think that the data for Brp IHC in *wnd* mutants added an additional layer of confusion: in the initial manuscript (previously [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}) we saw that Brp levels were slightly reduced in *wnd* mutants, which contrasts with the enhanced levels we observed for SV associated proteins VGlut and Syt1 at early stages of synapse development. We argued in our appeal that this difference does not negate the model: since very little is known about how different AZ and SV proteins are regulated developmentally, there is no reason to predict or expect that Brp levels would be sufficiently high in stage 15-17 animals to be subject to restraint by Wnd signaling.

Since our observations with Brp did not negate the model but instead opened up new questions, we realized that it is more distracting than it is useful given our current state of knowledge. So we have decided to remove this data from the revised manuscript.

> The authors should also clarify their model for how synaptic protein levels are regulated in the unc-104 mutants (though the authors do discuss the RT-PCR data and I agree with them that RT-PCR detects transcripts from all the cell types in all the tissues used for the mRNA prep, and does not account for specific defects in protein levels and localization at the neuronal cell bodies and synaptic terminals). The main point of the paper does not hinge on a particular model of synaptic protein level control, but the authors do need to clarify their explanations, either in the text or with more experiments.

As agreed by the reviewer, the major effect we observed by IHC on presynaptic protein expression occurs in motoneurons. Since the RT-PCR data was obtained from the entire larval CNS, this data is limited in sensitivity and utility for making conclusions about any changes in mRNA levels in motoneurons. Therefore we have removed this data (previously [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}).

And, as requested, we have now added further discussion for the question of HOW Wnd signaling may be regulating presynaptic protein levels, quoted below:

Quoting from revised text, in the Results:

"These observations, combined with the observations that Wnd activation reduces the levels of Brp and VGlut at NMJs, suggest a model in which activated Wnd signaling leads to a down-regulation of the expression levels of multiple pre-synaptic proteins in *unc-104* mutants. \[...\] This, together with the involvement of transcription factor Fos in restraining VGlut and Brp buildup in cell bodies ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}), implies that Wnd signaling may inhibit presynaptic protein expression at the transcriptional level."

And in Discussion:

"How does Wnd signaling regulate presynaptic proteins? \[...\] On the other hand, previous studies have separately linked Unc-104, Wnd signaling and AP-1 (Fos) to autophagy (Guo et al., 2012; Shen and Ganetzky, 2009; Stavoe et al., 2016). It will be interesting to determine whether translation and/or autophagy contribute to the regulation of presynaptic proteins by Wnd signaling."

> Wnd null mutants alone should be included in [Figure 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"} for comparison in this specific assay.

Our revision includes these controls side-by-side in the figures for comparison. Due to our reorganization the previous [Figure 5](#fig5){ref-type="fig"} (suppression of the *unc-104-null* phenotype) is now [Figure 1](#fig1){ref-type="fig"}, and the previous [Figure 6](#fig6){ref-type="fig"} (dramatically elevated presynaptic protein in *unc-104;wnd-null* mutant embryos) is now [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. For these phenotypes the *wnd* single mutants resemble wild type animals.

> However, though phenotypes in transheterozygotes can be informative, lack of a dominant transheterozygote phenotype might just reflect gene dose requirements, and so we did not put as much weight on that particular experiment.

We have examined synaptic defects of transheterozygotes (*unc-104^bris/P350^;wnd^3/+^*) and found that heterozygous mutations in *wnd* fail to dominantly suppress the *unc-104* defects. Since this observation neither proves nor negates the overarching model, we decided not to include this data.

> Electrophysiological analysis (and synaptic vesicle protein levels) in wnd overexpression lines would provide strong corroboration that increased Wnd explains functional defects in unc-104 mutants.

This was a great suggestion -- this experiment provides more direct evidence than the analysis of hiw phenotypes (which is now moved to supplementary data). We provided these analysis in the revision, in [Figure 6B and 6D](#fig6){ref-type="fig"}-I.

Quoting from subsection "Activation of the Wnd signaling pathway in neurons is sufficient to impair presynaptic structure and synaptic transmission":

..."Indeed, over-expression of *wnd* alone in motoneurons resulted in cell-autonomous presynaptic defects that are comparable to *unc-104* mutants. \[...\]Taken together with the rescue of *unc-104* synaptic defects by *wnd* mutations ([Figures 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}), these data indicate that activation of Wnd signaling leads to strong perturbations in presynaptic structure and function."

> Addressing the discrepancy with previous results (Collins 2006) on Wnd suppression of the hiw phenotype will be also be important.

First, it is important to clarify that our cumulative electrophysiological observations in the paper suggest that activation of the Wnd pathway does not strongly impair quantal content. Instead, the strongest and most salient defect caused by Wnd pathway activation is a reduction in spontaneous mEJP frequency. The frequency of detectable mEJP events was reduced in *unc-104^bris/P350^* and *hiw^ΔN^* mutants by \~70% and \~80%, respectively, and this defect was fully suppressed by mutations in *wnd* as well as downstream signaling components *bsk* and *fos* ([Figure 3A, 3C](#fig3){ref-type="fig"} and [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Also, mEJP frequency becomes strongly reduced when Wnd is ectopically expressed ([Figure 6D and F](#fig6){ref-type="fig"}). We also observed modest but statistically significant reductions in mEJP amplitude mediated by Wnd ([Figure 3D](#fig3){ref-type="fig"}, [6G](#fig6){ref-type="fig"} and [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). These observations are consistent with the data reported for Wnd-mediated synaptic transmission defects in *hiw^ND8^* mutants in the 2006 study. The 2006 study did not quantify mEJP frequency, but the effect is apparent in the published traces, and is now quantified in our partial repeat of that data ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}).

The only difference between our findings and the 2006 study was that the 2006 study showed that *wnd* mutations failed to suppress *hiw* defects in quantal content, while our data suggested that quantal content defects may be partially suppressed by *wnd* mutations. The two studies used different alleles of *hiw* and *wnd*, so to understand the basis for the differences, we carried out additional electrophysiology recordings for multiple allele combinations for side-by-side comparisons ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Confirming/repeating the 2006 result, *hiw^ND8^; wnd^1/2^* double mutants showed the same defects in quantal content as *hiw^ND8^* mutants alone. The partial rescue by *wnd^[@bib3]^/Df* mutations in *hiw^ΔN^*mutants is only of borderline significance (it was more significant when we used higher calcium bathing solution in our first submission). We noted that *hiw^ΔN^*, which is a true null allele (Wu et al., 2005) showed a slightly lower quantal content than *hiw ^ND8^*([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). This suggests the potential for a modest role of Wnd in the *hiw^ΔN^* quantal content phenotype, however further controls would be needed to fully address this possibility.

As discussed above, in contrast with the reduced mEJP frequency and mEJP size, altered quantal content is not a strong feature of Wnd pathway activation. So we have focused our conclusions in this study to the effect of Wnd pathway upon spontaneous rather than evoked neurotransmission.

> On the other hand, experiments to address the cellular function of hiw would be nice but are not essential to the main interesting points of the paper. If the authors have the data or a more clear model of the role of hiw, it would be helpful to include, but we don\'t think it\'s necessary.

We have provided a more clear discussion of the differences between *unc-104* mutants and *hiw* mutants:

Quoting from subsection "Wnd protein is mislocalized to the cell body in unc-104 mutants":

*... "*Mutations in *hiw* lead to strongly elevated levels of Wnd protein whose localization can be detected in neurites and at synapses (Collins et al., 2006). \[...\] These observations suggest that the mechanism of Wnd signaling activation in *unc-104* mutants is unlikely to occur via Hiw."

Interestingly, the activation of Wnd signaling in mutants for the spectroplakin shortstop (*shot)*(Valakh et al., 2013) bears more resemblance to *unc-104* mutants. (That is, in contrast to *hiw* mutants, and similarly to *unc-104* mutants, *shot* mutants also do not cause global increases in Wnd protein levels (Valakh et al., 2013)). Another recent study suggests that *shot, unc-104*, and *tau* mutants may influence a similar pathway (Voelzmann et al., 2016). This suggests a possibility that *unc-104* and *shot* mutants (which likely disrupt neuronal cytoskeleton) may share a similar mechanism of Wnd signaling activation.

> The rescue of the axon regrowth phenotype are not critical for the main conclusions of the paper and could take a lot of time.

We appreciate this point. We observed enhanced axonal growth after injury both in *unc-104-hypomorph/null* mutants and in independent RNAi lines for *unc-104* ([Figure 4E-G](#fig4){ref-type="fig"}). However showing rescue of this phenotype would require additional time.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Reviewer \#1:

> In their revised manuscript, the authors have been very responsive to reviewer suggestions. The logical flow of the manuscript is significantly improved and experimental concerns directly addressed.
>
> I have one question regarding the addition of wnd null data to [Figure 1](#fig1){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. Is it still accurate to state that \"Control and Experimental animals were always dissected, fixed and stained in the same dish/slide and imaged in parallel using identical confocal settings\" (Experimental Procedures,), or were the new data obtained in separate experiments and normalized to wild type for incorporation with previously obtained data?

Good point -- for the embryo data we needed to dissect and fix independently but these were fixed for the same time points and imaged in parallel with identical settings. We have modified the quoted text to be more accurate by replacing "same dish/slide" with "same condition". See subsection "Immunocytochemistry".
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